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INTRODUCTION 
 A high cervical spinal cord injury (SCI) in mammals often impairs respiratory motor 
function due to disruption of the bulbospinal pathway, the major pathway responsible for 
descending respiratory drive. The bulbospinal pathway transmits excitatory respiratory 
impulses from the right and left rostral ventral respiratory groups (rVRGs) in the medulla to 
depolarize the phrenic nuclei (PN) in the third through sixth cervical spinal segments 
(DeVries and Goshgarian, 1989). The PN then transmits the excitatory impulse to the 
diaphragm via the phrenic nerves. The surgical model used in the following studies is a left 
hemisection at the second cervical spinal segment (C2Hx). The left C2Hx disrupts the 
ipsilateral rVRG axonal connections to the left phrenic nucleus and causes ipsilateral (left) 
hemidiaphragm paralysis (Fig. 1). Electromyogram (EMG) recordings of the diaphragm 
immediately after injury verify the loss of diaphragm activity (Fig. 2). 
A secondary latent pathway, the crossed phrenic pathway (CPP), consists of 
collateral axons from the contralateral and ipsilateral rVRGs that decussate rostral to or at 
the level of the PN (Fig. 1) (Porter, 1895; Moreno et al., 1992; for review Goshgarian, 2003). 
The axonal decussation is caudal to the C2Hx, and is therefore intact following injury. Under 
normal conditions the neurons involved in the CPP are in a latent state, meaning that they 
are not transmitting a signal from the rVRG to the PN to activate the diaphragm. In most 
cases, physiological evidence of the CPP can be demonstrated immediately after injury by 
the ability to produce an augmented breath (Fig. 2, arrows). An augmented breath occurs 
when descending respiratory drive from both rVRGs increase for a single breath. This 
activates the diaphragm bilaterally utilizing the non-injured pathway to the right 
hemidiaphragm and the CPP to the left hemidiaphragm (Fig. 1). An augmented breath is 
characteristically followed by a short period of apnea (Fig. 2) (Golder et al., 2001a).  
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Figure 1: Diagram of the bulbospinal pathway. The descending respiratory drive is 
carried by the descending bulbospinal respiratory pathways. Pre-motor neurons in the 
rostral ventral respiratory groups (rVRGs) located in the ventral medulla send impulses to 
the motoneurons of the phrenic nucleus located in the 3rd-6th cervical spinal segments. The 
motoneurons in the phrenic nuclei then stimulate the diaphragm to contract via the phrenic 
nerve. The location of the spinal hemisection at the second cervical segment is rostral to 
the decussation of the latent crossed phrenic pathway leaving these axons uninjured 
following a C2Hx. Arrows indicate the pathway over which respiratory impulses travel upon 
activation of the crossed phrenic pathway to restore function to the paralyzed 
hemidiaphragm under certain conditions. Figure from Phillis and Goshgarian, 2001. 
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Figure 2: EMG recording of the diaphragm immediately after C2Hx. EMG recording of 
left (top panel) hemidiaphragm (ipsilateral to C2Hx) and right (bottom panel) hemidiaphragm 
immediately following a C2Hx. Note that the left hemidiaphragm is paralyzed (lack of bursts) 
following the C2Hx, while the right hemidiaphragm is actively contracting. An augmented 
breath is demonstrated (arrows) followed by a short period of apnea. The augmented breath 
confirms the crossed phrenic pathway is intact following the C2Hx and is capable of 
contacting the diaphragm. The spikes on the left and right are EKG (electrocardiogram) 
waves. Buttry and Goshgarian, 2014. 
 However, in the rat model following a SCI the ipsilateral phrenic nerve can 
spontaneously regain phasic function over time (6 weeks or more) by utilizing the CPP 
(Nantwi et al., 1999; Golder et al., 2001a; Fuller et al., 2008). In addition, recovery can occur 
in a relatively short time frame with pharmacological activation (Nantwi et al., 1996; Nantwi 
et al., 2003a; Kajana and Goshgarian, 2008a) or within minutes to hours with a contralateral 
phrenicotomy (Porter, 1895 (dog); Goshgarian, 1979 (rat)). 
Pharmacological intervention following SCI to activate the latent CPP to regain 
diaphragm function holds great potential. Clinical use of theophylline (1,3-
dimethylxanthine), a methylxanthine, in man has been reported as early as 1922 (Schultze-
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Werninghaus and Meier-Sydow, 1982). Theophylline, acting as a bronchodilator, has been 
prescribed to treat symptoms of asthma, bronchitis, and emphysema (Aubier et al., 1981; 
Moro et al., 2006; Nantwi et al., 1996; Nantwi et al., 2002). Specifically, theophylline, a non-
selective phosphodiesterase inhibitor (Butcher and Sutherland, 1962; Horn and McAfee, 
1977), has been shown to enhance respiratory drive by acting as an adenosine receptor 
antagonist (Eldridge et al., 1983 and 1985; Nantwi and Goshgarian, 1998) that interferes 
with both A1 and A2 adenosine receptors (Nantwi et al., 1996). The return of diaphragm 
function can be transient or permanent based on the number and frequency of doses 
(Nantwi et al., 1996, 1x IV; Nantwi et al., 2003a, multiple oral).  
In rats following a C2Hx, systemic (oral or intravenous) administration of 
theophylline stimulated the CPP increasing respiratory output and resulted in recovery of 
function for both the phrenic nerve and diaphragm (Nantwi et al., 1996; Nantwi and 
Goshgarian, 2002).  However, there is limited documentation of clinical studies that 
investigate the use of theophylline in humans following SCI to increase respiratory drive 
(Ferguson et al., 1999; Bascom et al., 2005; Tzelepis et al., 2006). Lack of data in humans 
is due to the high therapeutic dose of theophylline required following SCI that can cause 
intolerable side effects including nausea, vomiting, nervousness, increased or irregular 
heartbeat, and insomnia (Aubier et al., 1981; Tzelepis et al., 2006; Barnes, 2013). These 
side effects are caused by a high concentration of the drug in the plasma leading to global 
phosphodiesterase inhibition and adenosine A1-receptor antagonism resulting in a 
hyperactive state of many non-targeted neurons (Barnes, 2013). Further efforts to 
investigate the clinical outcome of systemic theophylline administration have been 
abandoned due to intolerable side effects and lack of quality data.   
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Collectively, the past studies provide key information on the anatomy and function 
of the CPP that can be stimulated to re-direct the descending respiratory drive following 
SCI. In addition, several drugs capable of stimulating the CPP have been characterized in 
vivo with rodent models. Unfortunately, systemic administration of theophylline at a 
therapeutic dose causes intolerable side effects in humans. Therefore, an alternative 
method to administer theophylline was needed. Being able to target the drug to select 
respiratory nuclei holds the potential to greatly reduce the therapeutic dose and to reduce 
or eliminate unwanted side effects.  
The key to delivering a drug to select populations of respiratory nuclei is wheat germ 
agglutinin (WGA). WGA is a lectin that has an affinity to sugars, specifically N-acetyl-d-
glucosamine and sialic acid, which are components of glycoconjugates found on most 
neuronal cell membranes (Borges and Sidman, 1982; Fabian and Coulter, 1985; Robertson, 
1990). These substances act as neuronal cell membrane receptors when WGA is injected 
into muscle (Borges and Sidman, 1982; Fabian and Coulter, 1985; Robertson, 1990). As a 
consequence of binding to these specific receptor sites on the motor nerve terminal 
membranes, WGA undergoes receptor-mediated endocytosis (Borges and Sidman, 1982). 
Subsequently WGA is retrogradely transported along the axon within vesicles, lysosomes, 
cisternae and tubules. Following transport to the cell body, the above membrane 
compartments fuse and the transported lectin is incorporated into lysosomes (Schwab et 
al., 1979; Ruda and Coulter 1982; Broadwell and Balin, 1985). In the electron microscopic 
studies of Schwab et al. (1979), the selective release of WGA from postsynaptic dendrites 
followed by the rapid uptake of the lectin into presynaptic nerve terminals was observed. 
However, after counting the number of presynaptic terminals labeled the authors concluded 
that the retrograde transsynaptic transport capability of WGA was far less than other 
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macromolecules such as tetanus toxin (Schwab et al., 1979). The precise mechanism for 
the release of WGA from postsynaptic dendrites into the synaptic cleft is still unknown.  
Since the 1980s it has been suggested that there is a preferential release from 
postsynaptic dendrites of physiological active synaptic connections (Harrison et al., 1984, 
1986; Jankowska, 1985). This was initially determined by observing the location and 
number of labeled motoneurons and propriospinal neurons in the spinal cord of cats and 
rats following the injection of wheat germ agglutinin conjugated to horseradish peroxidase 
(WGA-HRP) into motor nerves of chronically anesthetized and awake animals (Harrison et 
al., 1984; Jankowska, 1985). Furthermore, the extent of neuronal labeling was enhanced 
when the motor nerves were stimulated which facilitated synaptic activity to the 
motoneurons (Harrison et al., 1984; Jankowska, 1985). Commonly, as in these studies 
mentioned, WGA is conjugated with HRP in order to visualize the locations of WGA 
following injection. Phrenic motoneurons (PMNs) are unique in that they maintain a phasic 
discharge regardless of whether an animal is anesthetized or awake. Neurons in the rVRG 
are responsible for maintaining this discharge (Ellenberger and Feldman, 1988) and this is 
the presumed basis for the activity-dependent retrograde transsynaptic labeling of both 
PMNs and rVRG pre-motor neurons when WGA-HRP is injected into the diaphragm 
following a C2Hx (Moreno et al., 1992; Fig. 3).     
Based on the demonstration of transsynaptic transport of WGA-HRP in the phrenic 
motor system following SCI (Moreno et al., 1992), WGA-HRP was utilized to target drug 
delivery to the motoneurons of the PN and pre-motor rVRG neurons involved in respiration. 
In order to bind theophylline (or drug of choice) to WGA-HRP a carrier was needed to 
facilitate the chemical conjugation. In vivo application of gold (Au) nanoparticles (NPs) has 
been established in the literature and are known their biocompatibility and for easy 
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attachment of various structures via chemical bonds to the Au (De Jong et al, 2008; Chen 
et al., 2009; Duncan et al., 2010; Jain 2010; Thakor et al., 2011; Dreaden et al., 2011, 2012; 
Zhou et al., 2013; Cheng et al., 2013; Mieszawska et al., 2013). 
 
Figure 3: Images from rats that had a left C2Hx followed by a contralateral (right) 
phrenicotomy and ipsilateral (left) intradiaphragmatic injection of WGA-HRP. Fig. 8 
Photomicrograph of transverse section through the C4 level of the spinal cord in the 
hemisected rat expressing the crossed phrenic reflex. Note the phrenic motoneurons in the 
left PN that have been retrogradely labeled with WGA-HRP. Also note the absence of any 
labeled neurons in the right phrenic nucleus (solid black arrow) Fig.9 High power 
magnification of the labeled motoneurons of the left phrenic nucleus shown in Fig. 8 Fig. 10 
Photomicrograph of a transverse section through the medulla. In this spinal hemisected rat 
expressing the crossed phrenic reflex, note the neurons in both rVRGs (enclosed by 
rectangles) that have been transsynaptically labeled with WGA-HRP. P, pinhole on right. 
IV, fourth ventricle. XII, rostral pole of hypoglossal motor nucleus. Fig. 11 High power 
magnification of the area enclosed by the left rectangle in Fig. 10 showing transsynaptically 
labeled neurons of the left rVRG. Fig. 12 High power magnification of the area enclosed by 
the right rectangle in Fig. 10 showing transsynaptically labeled neurons of the right rVRG. 
Figure and caption from Moreno et al., 1992. 
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CHAPTER 1: WGA-ALEXA LABELING IN THE PHRENIC MOTOR SYSTEM 
Summary  
 The purpose of this study was to identify and compare the spinal and medullary 
centers involved in the respiratory pathway that activate the diaphragm in acutely injured 
and chronically injured C2Hx rats. The identification of spinal and medullary centers was 
accomplished by the following approaches: i) ipsilateral intradiaphragmatic injection of 
WGA-Alexa in the acutely and chronically C2Hx injured rat model, ii) topical application of 
WGA-Alexa to the ipsilateral phrenic nerve in the acute C2Hx injured model and in non-
injured rats, iii) unilateral intrapleural injection of WGA-Alexa in non-injured rats. 
Both intradiaphragmatic and intrapleural injections resulted in bilateral retrograde 
labeling of the phrenic nucleus (PN) and bilateral retrograde transsynaptic labeling of the 
rostral ventral respiratory groups (rVRGs). Unexpectedly both intradiaphragmatic and 
intrapleural injections also resulted in bilateral nucleus ambiguus (NA) labeling. In addition, 
following intrapleural injection WGA-Alexa was detected bilaterally in the intercostal motor 
nuclei of the thoracic spinal cord. Interestingly topical application of WGA-Alexa to the 
phrenic nerve result in only retrograde transport to the ipsilateral PN suggesting 
transsynaptic transport is dependent upon the site of application.  
 Spinal and medullary labeling following Intradiaphragmatic injection of WGA-Alexa 
in the acutely C2Hx injured rats compared to the chronically C2Hx rats were strikingly 
different. These differences in WGA-Alexa labeling patterns demonstrate injury-induced 
spinal and supraspinal plasticity that may contribute to spontaneous recovery of the 
diaphragm following injury.  
Introduction 
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 It has been well established that when WGA-HRP is injected into muscle it is 
transported in a retrograde fashion back to the motoneuron cell bodies and also 
transsynaptically to other neurons within the synaptic chain (Harrison et al., 1984, 1986; 
Porter et al., 1985; Moreno et al., 1992). In addition, it has been shown that the transsynaptic 
transport is selectively mediated across physiologically active connections rather than silent 
or less active connections (Harrison et al., 1984, 1986; Jankowska, 1985). To test the 
retrograde transsynaptic capability of WGA-HRP in the phrenic motor system, Moreno and 
colleagues (1992) injected WGA-HRP into the hemidiaphragm ipsilateral to a C2Hx after 
recovery of the hemidiaphragm was induced by cutting the contralateral phrenic nerve, 
activating the CPP. Moreno and colleagues found WGA-HRP labeling in the ipsilateral 
PMNs, and bilaterally in the medullary center that provides the excitatory drive to PMNs 
during inspiration, the rVRGs (Fig.3). Therefore, Moreno and colleagues (1992) 
demonstrated that retrograde transsynaptic transport of WGA-HRP also occurs in the 
phrenic motor system following cervical SCI.  
In recent years, investigators have become interested in identifying the intracellular 
molecular mechanisms and intracellular pathways which may mediate respiratory plasticity 
and recovery of the diaphragm after spinal cord injury (Kajana and Goshgarian, 2008a, 
2008b, 2009; MacFarlane and Mitchell, 2008; MacFarlane et al., 2009; Wilkerson and 
Mitchell, 2009). In order to study such intracellular molecular mechanisms, it would be 
advantageous to identify the physiologically active respiratory neurons in the spinal cord 
and brainstem that are most likely responsible for mediating the plasticity. This could be 
accomplished by using the retrograde transsynaptic transport capability of WGA-HRP 
following injections of the tracer into the hemidiaphragm. The identified neurons could then 
be isolated (e.g. by laser microdissection) and subjected to intracellular molecular analysis. 
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However, visualizing WGA-HRP requires exposure of the tissue sections to chemicals and 
reagents that may reduce the quality of the mRNA captured by laser microdissection 
(Gjerdrum et al., 2004; Mouledous et al., 2002; Wang et al., 2006). Several laboratories 
have documented this problem (Gjerdrum et al., 2004; Mouledous et al., 2002; Wang et al., 
2006) and in our own laboratory we found this to be the case. Therefore, we set out to 
investigate an alternative tracer, WGA-Alexa Fluor®, which may have the same retrograde 
transsynaptic capabilities as WGA-HRP, but without the requirement of visualizing the 
tracer by histochemical staining. In this case, WGA is conjugated to a fluorochrome (Alexa 
488 or Alexa 594) and can be visualized simply with a fluorescent microscope (Model et al., 
2009).  
The first aim of the present study was to determine if WGA-Alexa 488 would undergo 
retrograde transsynaptic transport in the phrenic motor system (i.e., labeling both PMNs 
and the rVRG) similar to WGA-HRP. To partly address the underlying mechanism for 
transsynaptic transport, the second aim was to investigate the pattern and extent of labeling 
that occurs when WGA-Alexa 488 is applied to the phrenic nerve isolated in the cervical 
region as compared to intradiaphragmatic injection. In the former case, the tracer diffuses 
into the exposed phrenic axons, while in the latter; WGA-Alexa 488 is actively taken up at 
the phrenic myoneural junction by WGA receptor-mediated endocytosis.  
 In the third aim, intradiaphragmatic injections of WGA-Alexa 488 were used to 
compare the anatomical pathways that innervate the diaphragm in acutely injured C2Hx 
rats to chronically injured C2Hx rats. Based on the observation that WGA-Alexa 488 is 
transsynaptically transported over select physiologically active synapses in the respiratory 
motor pathway, any changes in labeling pattern occurring over time after injury would 
primarily be due to changes in physiologically active synapses in the chronically injured 
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C2Hx rat. In addition, the changes in labeling pattern may reveal compensatory routes over 
which spontaneous recovery of the diaphragm is achieved after chronic spinal cord injury 
(Nantwi et al., 1999). 
Due to the invasive nature of the laparotomy procedure required for 
intradiaphragmatic injections, the fourth and final aim was designed to investigate a less 
invasive labeling technique, intrapleural injection. In 2009 Mantilla and colleagues 
introduced a new method of labeling PMNs by injecting cholera toxin subunit beta (CTB) 
conjugated to Alexa 488 bilaterally into the intrapleural space. Unfortunately, Mantilla and 
colleagues only presented data pertaining to the spinal cord; presumably because CTB-
Alexa 488 is not a transsynaptic tracer (Cabot et al., 1994, Lee et al., 2009) therefore one 
would not expect CTB-Alexa 488 to be identified in the rVRGs. The possibility of 
transsynaptic transport of a neuronal tracer to the rVRGs in the medulla following 
intrapleural injection remained unresolved. To verify the effectiveness of intrapleural 
injections versus intradiaphragmatic, each rat received injections in the intrapleural space 
and intradiaphragmatic injections allowing for the comparison of the two techniques. The 
studies detailed in the following 3 sections have already been published (Goshgarian and 
Buttry, 2014; Buttry and Goshgarian, 2014, 2015).  
The pattern and extent of retrograde transsynaptic transport of WGA-Alexa 488 in the 
phrenic motor system is dependent upon the site of application  
 
 Due to the damaging histochemical techniques required to visualize HRP, an 
alternative to the neuronal tracer WGA-HRP was needed to visualize the phrenic motor 
system following SCI. WGA conjugated to a fluorochrome, Alexa 488 was selected based 
on the characteristic that it can be visualized immediately after sectioning with a fluorescent 
microscope (Model et al., 2009). WGA-Alexa tracers are well established, exceptionally 
bright, and are excellent for tracing axonal pathways in the central nervous system (Reeber 
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et al., 2011a, 2011b; Yamazaki et al., 2009; Panchuk-Voloshina et al., 1999). In addition, 
WGA-Alexa 488 labeled cells have distinct granules that are clearly identifiable at higher 
magnifications (Fig. 4). Both anterograde (Reeber et al., 2011 a, 2011b) and retrograde 
(Yamazaki et al., 2009) track tracing studies have been conducted with WGA-Alexa 488. 
Transneuronal/transsynaptic transport of WGA-Alexa 488, however, has never been 
demonstrated in vivo. Thus, the first aim of the present study was to determine if WGA-
Alexa 488 would undergo retrograde transsynaptic transport in the phrenic motor system 
similar to WGA-HRP. In addition to partly address the underlying mechanism for WGA 
mediated transsynaptic transport, the second aim of the present study was to investigate 
the pattern and extent of labeling that occurs when WGA-Alexa 488 is applied to the cervical 
phrenic nerve as compared to intradiaphragmatic injection.  
Results 
All rats used to produce the following data received a left C2Hx or a sham C2Hx 
(see methods for details). Rats that received a C2Hx were included in the study only if they 
had complete left hemidiaphragm paralysis as confirmed by EMG analysis (Fig. 5).  A 
minimum survival period of 2 days was sufficient to obtain strong labeling in both the PN 
and rVRG.  
In all rats that received left hemidiaphragmatic injections of WGA-Alexa 488, 
bilateral labeling of the PN was observed (Fig. 6A). Furthermore, the observed spinal cord 
labeling was restricted to the PN only; there were no other labeled motoneurons, 
propriospinal neurons or dorsal horn neurons identified at the C3–C6 level of the spinal cord 
(Fig. 6A). The lack of WGA-Alexa 488 in the cervical spinal tissue with the exception of the 
PN demonstrates the selective uptake of WGA following intramuscular injection.  
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Figure 4: WGA-Alexa 488 granulation in labeled neurons. A high magnification of 
phrenic nuclei motoneurons displaying the granulation appearance of the WGA-Alexa 488 
neuronal tracer. Note the specks or granules visible within the cell bodies, axons and 
dendrites of the labeled neurons.  
 
 
Figure 5: Electromyogram of the diaphragm to confirm C2Hx. Electromyograms taken 
from both sides of the diaphragm from a rat that was subjected to left C2 spinal cord 
hemisection. Note that the right hemidiaphragm is not significantly affected by the 
hemisection and displays EMG bursting every time the rat takes a breath. The left 
hemidiaphragm, however, is completely paralyzed and does not display EMG activity. The 
spikes on the left and right are EKG (electrocardiogram) waves. Calibration bar: 1 s. 
Goshgarian and Buttry, 2014. 
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Figure 6: Labeling pattern following injection of 50 µl of 2% WGA-Alexa 488 into the 
left hemidiaphragm from a rat that was subjected to left C2Hx. (A) Low power view of 
a section through the C3 level of the spinal cord, displaying bilateral phrenic nucleus 
labeling. Note that there is no other neuron labeling in the spinal cord gray matter and 
suggests that the tracer diffuses across the midline of the diaphragm to label both phrenic 
nuclei. This same pattern of labeling was seen in all rats with a left hemidiaphragm injection. 
The pinhole (P) marks the right side (contralateral to injection). (B) and (C) Each rat 
receiving intradiaphragmatic injections of WGA-Alexa 488 also displayed bilateral labeling 
of the rVRG indicating retrograde transsynaptic transport. (B) Low power view of the labeled 
left rVRG (circled area). SNV, spinal nucleus of V, STV, spinal tract of V is indicated as 
landmarks. (C) Same magnification as in (B) showing the right rVRG (circled area) in the 
same rat. Note that there is no other medullary center labeled. Small arrows in both (B) and 
(C) point to small labeled non-neuronal cells associated with blood vessels. Calibration bar 
in (C), also pertains to (B). (D) Higher power view of the labeled left rVRG shown in (B). (E) 
Higher power view of the right rVRG shown in (C). Note granulation in both rVRG centers 
indicating positively labeled cells. Calibration bar shown in (E) also pertains to (D). 
Goshgarian and Buttry, 2014. 
 
 In addition, intradiaphragmatic injection of WGA-Alexa 488 resulted in bilateral 
labeling of the rVRGs in the medulla. The left (ipsilateral to injection) rVRG is shown in Fig. 
6B and D while the right rVRG (contralateral to injection) in the same rat is shown in Fig. 
6C and E. Note also the selectivity of the medullary labeling. The area of the rVRG is the 
only location labeled. Moreover, the rVRG was always labeled bilaterally (Fig. 6B and C). 
In particular, note the absence of labeling in neither gigantocellular reticulospinal neurons 
nor raphe neurons known to project to the phrenic nucleus (Dobbins and Feldman, 1994). 
 In contrast, when WGA-Alexa 488 was applied to the intact isolated left phrenic 
nerve, only ipsilateral phrenic nucleus labeling was observed (Fig. 7A). Isolated ipsilateral 
phrenic nucleus labeling was observed in all rats. Contralateral phrenic motoneuron labeling 
was never observed, nor was there any other spinal cord neurons labeled at the level of the 
phrenic nucleus (C3–C6, Fig. 7A). During the pilot studies various methods were tested to 
label the phrenic motor system with WGA-Alexa 488; (i) injected the transected or intact 
phrenic nerve with the tracer, (ii) applied WGA-Alexa 488-soaked gelfoam to the exposed 
phrenic nerve or (iii) attempted to isolate the phrenic nerve with Parafilm® before applying 
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the tracer. All of these attempts yielded spurious labeling of phrenic and non-phrenic 
neurons in the cervical spinal cord. It was only when we isolated the phrenic nerve and 
contained the tracer in a cup (Fig. 8) that we achieved consistent ipsilateral phrenic nucleus 
labeling exclusively.  
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Figure 7: Labeling pattern shown following WGA-Alexa 488 application for 1 h to the 
left phrenic nerve from a rat that was subjected to left C2Hx. (A) Low power view of the 
C4 level of the spinal cord showing phrenic nucleus labeling only on the left side (ipsilateral 
to nerve application). The pinhole (P) marks the right side of the spinal cord. Note that no 
other neurons are labeled in the spinal cord other than the ipsilateral PN. Also note that the 
PN is as intensely labeled as it is following diaphragm injection of the tracer (compare this 
figure with Fig. 6A). Left (B) and right (C) sides of the medulla at the level of the rVRG 
(circled areas in both (B) and (C)). Note that the rVRGs are not labeled suggesting that 
retrograde transsynaptic transport does not occur when the tracer is applied to the phrenic 
nerve. SNV, spinal nucleus of V; STV, spinal tract of V is included as landmarks. These 
sections are comparable to the sections shown in Fig. 6B and C. Magnification in (B) is the 
same as in (C). (D) Higher power view of the rVRG shown in (B) (circled area). (E) Higher 
power view of the rVRG shown in (C) (circled area). Note that there is no granulation in the 
rVRG neurons indicating that they are not labeled. In order to see these unlabeled centers, 
the intensity of the fluorescent scope was increased substantially. Compare background 
intensity shown in Fig. 6D and E with these figures. Magnification of (D) is the same as (E). 
Goshgarian and Buttry, 2014. 
 
 
Figure 8: Photographs of the surgical exposure of the left phrenic nerve and the 
application of WGA-Alexa 488 to the nerve for 1 h. In all photographs, caudal is at the 
top, rostral is at the bottom, lateral is to the left and medial is to the right. (A) Surgical 
exposure of the phrenic nerve (PN) as it lays on the ventral surface of the brachial plexus 
(BP) before the application of the tracer. V, vagus nerve; C, carotid artery; J, jugular vein. 
(B) During the application of the tracer, a cup containing 1.5 _l of 2% WGA-Alexa 488 is 
placed so that the nerve is bathed in the solution. Bench top paper (B) is placed in the 
surrounding tissue to absorb fluid from the rat during the application period. (C) After the 1 
h application period, the cup and the bench top paper is removed and the tissue is gently 
swabbed. Note that the phrenic nerve (PN) has a yellow color indicating that the tracer 
diffused into the nerve. Scale bar is 3 mm. Goshgarian and Buttry, 2014. 
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Interestingly, following the application of WGA-Alexa 488 to the isolated phrenic 
nerve, there was no retrograde transsynaptic labeling to the rVRGs or any other medullary 
neuronal center observed in any of the rats (Fig. 7B–E). Fig. 7B and C is a section through 
the rVRG from a rat in which the phrenic nerve was soaked in WGA-Alexa 488. The 
unlabeled left and right rVRG can be seen at low magnification (Fig. 7B and C respectively) 
and a higher power view of each is shown (Fig. 7D and E). The medullary level is 
comparable to the level showing the labeled rVRGs in (Fig. 6B–E) in which WGA-Alexa 488 
was injected into the diaphragm. Initially, because of the activity-dependent nature of 
transsynaptic transport using WGA-HRP (Harrison et al., 1984, 1986; Moreno et al., 1992), 
we thought there may be a difference in the labeling pattern occurring when WGA-Alexa 
488 was applied to the quiescent phrenic nerve (i.e. ipsilateral to a C2 hemisection) versus 
an active phrenic nerve (ipsilateral to sham hemisection). However, there was no notable 
difference between the C2Hx group and the sham group. Following nerve application, the 
only labeled neurons detected were ipsilateral phrenic neurons regardless of whether the 
phrenic nerve was quiescent or active.  
Discussion  
The ability to transsynaptically label PMNs and pre-motor rVRG neurons 
responsible for descending respiratory drive (Ellenberger and Feldman, 1988) provides an 
anatomical picture to compare various states of the phrenic motor system following spinal 
cord injury (Goshgarian et al., 1991). This study shows that retrograde transsynaptic 
transport of WGA-Alexa 488 occurs in the phrenic motor system (i.e., bilaterally labeling 
PMNs and rVRG pre-motor neurons) when the tracer is injected intradiaphragmatically 
similar to WGA-HRP. The bilateral phrenic nucleus labeling was most likely due to WGA-
Alexa 488 diffusing within the muscle across the midline from the left hemidiaphragm to the 
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right and being taken up by the axon terminals in both phrenic nerves since peripheral 
crossing of phrenic axons has not been demonstrated in the rat diaphragm (Laskowski and 
Sanes, 1987). The right phrenic nerve (RPN) was not cut in the present study as it was in 
a previous study investigating WGA-HRP (Moreno et al., 1992). The primary reason the 
RPN was not cut was based on the observation that the crossed phrenic phenomenon 
(induced by C2Hx and contralateral phrenicotomy) contributes little to the overall ventilation 
of the animal (Fuller et al., 2006) and thus, we did not want to subject the experimental 
animals to unnecessary respiratory stress. 
Bilateral PN labeling following an ipsilateral diaphragm injection is not a unique 
finding. Boulenguez et al. (2007) showed that dependent upon the monosynaptic retrograde 
fluorescent tracer injected unilaterally in the rat diaphragm, PMNs would be labeled either 
bilaterally, ipsilateral, or not at all. Very similar results were observed after horseradish 
peroxidase (HRP) injection. Interestingly, injection of the dextran amine, fluororuby and the 
carbocyanine, DiAsp, into one hemidiaphragm, always resulted in the exclusive labeling of 
ipsilateral PMNs. The authors suggested that the lipophilic properties of DiAsp and the high 
molecular weight of fluororuby may prevent their diffusion to adjacent tissues and into the 
bloodstream which may have caused the artifactual labeling observed with Fluorogold and 
HRP (Boulenguez et al., 2007). The present results show that WGA-Alexa 488 is an 
excellent retrograde transsynaptic fluorescent tracer in the phrenic motor system, however 
there is consistent diffusion of the tracer in the diaphragm. To prevent bilateral PN labeling, 
the addition of a contralateral phrenicotomy to the surgical procedure remains a feasible 
option.  
 Exposure of WGA-Alexa 488 directly to the left phrenic nerve in both C2 hemisected 
and sham-hemisected rats was used to assess possible differences between quiescent and 
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functionally active PMNs. In spite of the observation that there was WGA-Alexa 488 labeling 
isolated to ipsilateral PMNs following application of the tracer to the nerve, there was no 
observed transsynaptic labeling to the rVRG in either the C2Hx or sham-hemisected 
groups. Based on past studies utilizing alternative tracers in the phrenic motor system (e.g. 
HRP, Goshgarian and Rafols, 1981, 1984; CT-HRP, Furicchia and Goshgarian, 1987; and 
WGA-HRP, Moreno et al., 1992), a difference in labeling pattern dependent on the site of 
tracer administration (i.e. nerve versus diaphragm) has never been reported. The reason 
for this difference in labeling pattern may be due to the differences in the mechanisms of 
uptake and transport of WGA in the nervous system when the tracer is injected into muscle 
versus tracer application to the nerve. Since the phrenic nerve was stripped of its 
epineurium and WGA-Alexa 488 was applied directly to the nerve, the tracer may have 
entered the nerve primarily by simple diffusion (i.e., not by a receptor-mediated uptake 
mechanism). Once within the nerve, the retrograde transport of the tracer back to the cell 
body may have occurred as described by Schwab et al. (1979), however, transsynaptic 
transport did not occur. Since it has been shown that lectin binding sites are not distributed 
uniformly on individual neurons (Hatten et al., 1979), it is possible that WGA-Alexa 488 must 
be applied at the phrenic myoneural junction where there may be a high concentration of 
WGA receptors in order for transsynaptic transport to occur (Fabian and Coulter, 1985; 
Robertson, 1990). The result of the present study is that HRP is not necessary for retrograde 
transsynaptic transport in the phrenic motor system; WGA alone, or in this case WGA 
conjugated to Alexa, is sufficient to mediate the transport (suggested by Borges and 
Sidman, 1982).  
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Injection of WGA-Alexa 488 into the ipsilateral hemidiaphragm of acutely and 
chronically C2 hemisected rats reveal activity-dependent synaptic plasticity in the 
respiratory motor pathways 
 
Based on the data obtained from the acute C2Hx injury model it is suggested that 
WGA-Alexa 488 is capable of transsynaptic transport in vivo across select physiologically 
active synapses in the phrenic motor system (Goshgarian and Buttry, 2014) similar to that 
of WGA-HRP (Moreno et al., 1992). It is likely that the synaptic transfer occurs preferentially 
over the connections (i.e. rVRG synapses) that depolarize the PMNs during inspiration 
(Ellenberger and Feldman, 1988).  
In contrast, Pseudorabies virus Bartha strain (PRV-Bartha), a retrograde 
transsynaptic neuronal tracer, demonstrates a diverse pattern of labeling compared to 
WGA-Alexa 488 when applied to the phrenic motor system. Following PRV-Bartha 
exposure to the diaphragm there is an increase in cell types positive for PRV-Bartha, 
compared to cell types positive for WGA-Alexa 488. This is likely due to the ability of PRV-
Bartha to cross all synaptic connections; not just physiologically active synapses (Lane et 
al., 2008). Thus, the retrograde transsynaptic transport of PRV-Bartha does not differentiate 
plasticity occurring over physiologically active connections versus less active or inactive 
connections. Specifically, when PRV-Bartha is applied to the diaphragm after an acute 
C2Hx or in non-injured rats, the tracer is detected in ipsilateral PMNs within 48 h, 
interneurons bilaterally in laminae VII and X of the cervical cord at 64 h, and cells in the 
dorsal horn bilaterally at 72 h (Lane et al., 2008). These results are consistent with those 
documented by Dobbins and Feldman (1994) who injected PRV into the phrenic nerve. In 
the only major chronic study using PRV as a retrograde tracer in which C2Hx rats survived 
up to twelve weeks post C2Hx (Lane et al., 2009), the authors found that the ratio of 
interneurons to motoneurons in laminae VII and X both ipsilateral and contralateral to the 
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injury site were significantly reduced (though still present) in the chronically C2Hx rats. No 
other significant changes were detected after both qualitative and quantitative analyses. 
Based on the previously observed transsynaptic labeling properties of WGA-Alexa 
488 over select physiologically active synapses in the respiratory motor pathway in the 
acute C2Hx injury model; any changes in labeling pattern occurring over time after injury 
would primarily be due to changes in physiologically active synapses. Furthermore, the 
changes in labeling pattern may reveal compensatory routes over which spontaneous 
recovery of the diaphragm is achieved after chronic spinal cord injury (Nantwi et al., 1999). 
To determine if there are changes in physiologically active synapses in the chronically 
injured system, WGA-Alexa 488 labeling patterns were compared between acutely and 
chronically injured C2 hemisected rats.  
Results 
Immediately following the C2Hx surgical procedure, an EMG of the diaphragm 
assessed the extent of hemidiaphragmatic paralysis (Fig. 2). Characteristic of C2Hx rats, 
an “augmented breath” (Fig. 2, arrows, Golder et al., 2001b) confirmed the presence of an 
intact crossed phrenic pathway (Moreno et al., 1992), over which spontaneous recovery of 
the C2Hx paralyzed hemidiaphragm is thought to occur (Nantwi et al., 1999). The sham 
C2Hx rats received a C2Hx procedure omitting the actual cut to the cervical spinal cord. 
The sham C2Hx rats showed no sign of diaphragm paralysis (Fig. 9).  
A second EMG was assessed in the chronic C2Hx and sham rats at immediately 
prior to intradiaphragmatic injections of WGA-Alexa 488 to assess the extent of 
spontaneous recovery (Fig. 10). Sixty-two percent of the chronically C2Hx rats showed 
spontaneous diaphragm recovery based on the return of muscle contractions of the 
ipsilateral hemidiaphragm (Fig. 10, top trace). The chronic sham rats displayed right and 
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left hemidiaphragm activity similar to the initial EMG following the sham C2Hx procedure 
(Fig. 11).  
 
Figure 9:  EMG traces from the left and right hemidiaphragm immediately after a 
Sham C2Hx. Note that the left hemidiaphragm (top trace) is still intact and functional and 
the bursting pattern matches the bursts of the right hemidiaphragm (bottom trace). The 
sharp spikes in all traces are EKG activity.  
 
Figure 10: EMG traces from the left and right hemidiaphragm 22 weeks post C2Hx. 
This recording was taken from the same rat used in figure 2. There is a moderate return of 
the bursting pattern in the left hemidiaphragm (top trace) indicative of spontaneous 
recovery. The bursts in the left hemidiaphragm match those in the right hemidiaphragm 
(bottom trace). Buttry and Goshgarian, 2014. 
24 
 
 
Figure 11:  EMG traces from the left and right hemidiaphragm 8 weeks after a Sham 
C2Hx. Note that the left hemidiaphragm (top trace) is still intact and functional and the 
bursting pattern matches the bursts of the right hemidiaphragm (bottom trace). The sharp 
spikes in all traces are EKG activity. Right electrodes were producing excessive noise 
during the recordings resulting in a larger background signal. 
 
 
Analysis of the spinal and medulla tissue from the acutely C2 hemisected rats was 
consistent with past studies (Goshgarian and Buttry, 2014). In the previous study only the 
cervical spinal cord at the level of the PN was examined, but in the present study, both 
cervical and thoracic spinal cord tissue was examined. The great majority of cells that 
contained WGA-Alexa 488 were PMNs at the C3-C6 levels of the spinal cord (Figs. 12A–
C), and the rVRG pre-motor neurons in the medulla (Figs. 12D & E). There were no other 
neurons labeled at the C3–C6 levels of the spinal cord or in the medulla of the acute C2Hx 
rats. However, WGA-Alexa 488 labeling was found in non-neuronal cells associated with 
the blood vessels in the medulla (Figs. 12D&E arrows; Goshgarian and Buttry, 2014), as 
well as a small number of neurons along the medial ventral border of the ventral horn caudal 
to the PN at C7 (Fig. 13A). 
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Figure 12: Spinal cord and medulla sections from an acute C2Hx rat following WGA-
Alexa 488 injection. A, Spinal cord section at the C4 level showing bilateral WGA-Alexa 
488 labeling in the phrenic nucleus (encircled areas). Note the absence of WGA-Alexa 488 
in any other nuclei. P, pinhole marks contralateral to hemisection. B, Higher magnification 
of ipsilateral phrenic nucleus from A. C, Higher magnification of contralateral phrenic 
nucleus from A. D, Ipsilateral rVRG (dashed encircled area) in the medulla. E, Contralateral 
rVRG (dashed encircled area) in the medulla. Note the absence of WGA-Alexa 488 in any 
other neurons. Both D and E show some non-neuronal cells with WGA-Alexa 488 labeling 
associated with the blood vessels (arrows). Buttry and Goshgarian, 2014. 
  
Figure 13: C7 spinal cord sections from an acute and a chronic C2Hx rat. A, Spinal 
cord section below the level of the phrenic nuclei at C7 of an acute C2Hx rat showing WGA-
Alexa 488 labeled neurons (large arrow) along the ipsilateral medal ventral border of the 
ventral horn. Note the lack of any additional labeled nuclei. B, Spinal cord section at the C7 
level of a chronic C2Hx rat with a WGA-Alexa 488 labeled neuron (large arrow) in the same 
area as the neurons shown in A. In addition, there is ipsilateral labeling of the dorsal 
spinocerebellar tract (dashed encircled area), and interneurons in laminae VII and VIII 
(small arrows). Buttry and Goshgarian, 2014. 
After a minimum 7-week recovery period, the chronic sham rats were injected with 
WGA-Alexa 488 into the left hemidiaphragm. Analysis of the spinal and medulla tissues 
revealed bilateral WGA-Alexa 488 labeling in PMNs, neurons along the medial ventral 
border of the ventral horn in the cervical cord caudal to the PN, and the rVRG pre-motor 
neurons in the medulla were detected in all 3 chronic sham rats. In addition, there were 
bilateral WGA-Alexa 488 labeled interneurons primarily in laminae VII and VIII of the 
cervical and thoracic cord and bilateral WGA-Alexa 488 labeled intercostal motoneurons in 
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the thoracic cord. No other neurons or tracts were detected in the medulla, cervical or 
thoracic spinal cord of the chronic sham rats. 
The chronically C2Hx rats received WGA-Alexa 488 intradiaphragmatic injections 
after a minimum 7-week recovery period. Five of the chronic C2Hx rats exhibited autophagy 
of the hind contralateral paw. Due to animal care policy, the severity of the autophagy 
determined the endpoint for these rats. Upon analysis of the spinal and medulla tissues 
there were no qualitative differences in the WGA-Alexa 488 labeling pattern regardless of 
the endpoint. Therefore, all rats were grouped together in a single chronic group.  
All chronic C2Hx rats exhibited bilateral WGA-Alexa 488 labeling of PMNs at the 
levels of C3–C6 (Figs. 14A & C). In addition, chronic C2Hx rats displayed neurons along 
the medial ventral border of the ventral horn caudal to the PN at the C7 level of the spinal 
cord (Fig. 13B). WGA-Alexa 488 labeled interneurons were detected bilaterally throughout 
the gray matter in all sections examined, primarily in laminae VII and VIII in the C4–T5 
region (Figs. 13B, 14, 15B & 16B). Unique to the chronic C2Hx rats was the labeled axons 
of the reticulospinal tract (RST) (Fig. 14C), ventral spinocerebellar tract (VSCT) (Fig. 14C), 
and dorsal spinocerebellar tract (DSCT) (Figs. 13B, 14C & 15B). All 3 tracts were labeled 
strictly ipsilateral to the injury. In all cases the DSCT and VSCT appeared as a fasciculated 
group of axons just lateral to the dorsal horn and just lateral to the ventrolateral sulcus, 
respectively. The DSCT was identified as far caudal as T5. The RST had a scattered 
appearance of axons throughout the lateral funiculus and was present in the upper and mid 
cervical regions of the spinal cord. Caudal to the PN in the region of C8/T1, motoneurons 
were identified in the motor nuclei for the triceps brachii and were bilaterally labeled with 
WGA-Alexa 488 (Fig. 15B). In addition, the motoneurons for the manus (hand) and/or 
forearm extensors were bilaterally labeled (Fig. 15B). The rostral/caudal transition from 
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forearm to manus could not be clearly identified with absolute certainty. In the thoracic cord 
of chronically hemisected rats, predominately at T3–T5, intercostal motoneurons were 
bilaterally labeled with WGA-Alexa 488 (Fig. 16B).  
 
Figure 14: C4/C5 spinal cord sections of a chronic C2Hx rat. A, Spinal cord section at 
the C4/C5 level showing WGA-Alexa 488 labeling in the phrenic nuclei (solid encircled area) 
and labeling in neuronal cells throughout laminae VII and VIII (dashed encircled area and 
arrows). B, Higher magnification of dashed encircled area in A showing WGA-Alexa 488 
labeling in neuronal cells located in laminae VII and VIII. C, Spinal cord section at the C3 
level of a chronic C2Hx rat with bilateral phrenic nuclei (encircled areas) labeling in the 
ventral horn. Note also the ipsilateral labeling of the dorsal spinocerebellar tract (dashed 
encircled area), ventral spinocerebellar tract (large arrow), and reticulospinal tract (small 
arrows) in the lateral funiculus. Note the labeling of neuronal cells throughout laminae VII 
and VIII (compare to lack of labeling in Fig. 2A). P, pinhole marks contralateral to 
hemisection. Buttry and Goshgarian, 2014. 
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Figure 15: C8/T1 spinal cord sections from an acute and a chronic C2Hx rat. A, Spinal 
cord section at the C8/T1 level from an acute C2Hx rat showing a complete absence of 
WGA-Alexa 488 labeling. B, Spinal cord section at the C8/T1 level from a chronic C2Hx rat 
showing ipsilateral labeling of the dorsal spinocerebellar tract (dashed encircled area), as 
well as bilateral labeling of triceps brachii motoneurons (large arrows), and forearm/manus 
motoneurons (small arrows). Compare to lack of labeling in A. P, pinhole marks 
contralateral to hemisection. Buttry and Goshgarian, 2014. 
 
Figure 16: T4/T5 spinal cord sections from an acute and a chronic C2Hx rat. A, Spinal 
cord section at the T4/T5 level from an acute C2Hx rat showing a complete absence of 
WGA-Alexa 488 labeling. B, Spinal cord section at the T4/T5 level from a chronic C2Hx rat 
showing bilateral WGA-Alexa 488 labeled intercostal motoneurons (dashed encircled 
areas). Buttry and Goshgarian, 2014. 
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The chronic C2Hx rats displayed a very distinct bilateral pattern of medullary labeling 
that was consistently detected in all chronic C2Hx rats; a summary of the labeled areas for 
the acute C2Hx and chronic C2Hx rats is shown in Fig. 17. In addition to the rVRGs, chronic 
C2Hx rats displayed a scattering of raphe neurons that were bilaterally labeled along the 
midline (Fig. 18B). Neurons were also labeled in the gigantocellular reticular nuclei (Fig. 
18B). The parvicellular reticular nuclei (PRN) were labeled and appeared as a column of 
neurons extending tangentially along the dorso-ventral plane (Figs. 18B & 19). The labeled 
neurons of the intermediate reticular nuclei were located dorsal to the rVRGs and in a 
grouping that at times reached just medial to the most dorsal portion of the labeled neurons 
in the PRN (Figs. 18B & 19). The spinal trigeminal nucleus had a scattering of labeled 
neurons throughout the nucleus (Fig. 18B). Lastly, neurons were bilaterally labeled 
throughout the hypoglossal nuclei (Fig. 20B). Interestingly, the sham rats showed labeling 
only in the rVRG. A summary of the anatomical results is presented in Table 1. 
 
 
Table 1: Location of WGA-Alexa 488 labeling in the medulla and spinal cord of the 
acute C2Hx, chronic sham, and chronic C2Hx rats.  Buttry and Goshgarian, 2014. 
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Figure 17: Drawings of the medulla summarizing all the locations of WGA-Alexa 488 
in the acute C2Hx and Chronic C2Hx rats. WGA-Alexa 488 labeled cells and tracts 
(darkened areas) in the acute C2Hx rats (A) and in the chronic C2Hx rats (B). A, In the 
acute C2Hx rats only the rVRG is labeled bilaterally. B, In the chronic C2Hx rats bilateral 
labeling is seen in: rVRG, rostral ventral respiratory group; XII, hypoglossal nucleus; R, 
raphe nucleus; Gi, gigantocellular reticular nucleus; I, intermediate reticular nucleus; P, 
parvicellular reticular nucleus; V, spinal trigeminal nucleus. IV, fourth ventricle and StV, 
spinal tract of V noted as landmarks. Buttry and Goshgarian, 2014. 
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Figure 18: Medulla sections from an acute and a chronic C2Hx rat.  A, Section from an 
acute C2Hx rat showing the medulla with WGA-Alexa 488 labeling in the ipsilateral rVRG. 
The contralateral rVRG is not shown at this magnification. B, Section from a chronic C2Hx 
rat showing the medulla with WGA-Alexa 488 labeling in the intermediate reticular nucleus 
(small white arrow), parvicellular reticular nucleus (large white arrows), rVRG (solid 
encircled area), raphe (gray arrows), spinal nucleus of V (small dashed arrows), and 
gigantocellular reticular nuclei (dashed encircled area). Buttry and Goshgarian, 2014. 
 
Figure 19: Medulla sections from a chronic C2Hx rat. A, Section from a chronic C2Hx 
rat medulla with ipsilateral WGA-Alexa 488 labeling in the intermediate reticular nucleus 
(small arrows), parvicellular reticular nucleus (large arrows), and rVRG (encircled area). B, 
Section from the same chronic C2Hx rat medulla as A with contralateral WGA-Alexa 488 
labeling in the intermediate reticular nuclei (small white arrow), parvicellular reticular nuclei 
(large arrow), and part of the rVRG (encircled area). Buttry and Goshgarian, 2014. 
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Figure 20: Hypoglossal nuclei from an acute and a chronic C2Hx rat. A, Section from 
an acute C2Hx rat showing the medulla with a complete lack of WGA-Alexa 488within the 
hypoglossal nuclei. B, Section from a chronic C2Hx rat showing the same level of the 
medulla (caudal to the rVRG) with bilateral hypoglossal nuclei WGA-Alexa 488 labeling. IV, 
fourth ventricle noted as a landmark. Buttry and Goshgarian, 2014. 
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Discussion  
The isolated PN and rVRGs labeling of the phrenic motor system following 
intradiaphragmatic injection of WGA-Alexa 488 in the acutely injured C2Hx model 
demonstrates the selective transsynaptic transport of WGA bound tracers over 
physiologically active synapses as previously described in other motor systems (Harrison 
et al., 1984, 1986; Jankowska, 1985; Schwab et al., 1979). It has been shown that WGA 
selectively binds to N-Acetyl-D-glucosamine and sialic acid on the neuronal cell membrane 
and undergoes receptor mediated endocytosis (Fabian and Coulter, 1985; Robertson, 
1990; Schwab et al., 1979). In addition, following injection of WGA-HRP, the number and 
location of WGA-HRP labeled motoneurons and propriospinal neurons in the spinal cord 
were compared between two groups; awake animals and chronically anesthetized animals. 
Two studies concluded that motor activity of the injected nerve was necessary for 
transsynaptic transport to occur from the motoneurons to the propriospinal neurons 
(Harrison et al., 1986 and Jankowska, 1985). Specifically, if the animals were chronically 
anesthetized and immobilized, the transsynaptic transport was minimal, whereas 
transsynaptic transport increased upon motor nerve stimulation (Harrison et al., 1984; 
Harrison et al., 1986; Jankowska, 1985) In contrast, alternative neuronal tracers that are 
transported independent of nerve activity have displayed labeling of additional medullary 
nuclei and cervical spinal interneurons in C2Hx rat models. For example, injection of 
Fluorogold, a monosynaptic tracer, into the phrenic nucleus post-C2Hx or sham C2Hx, 
results in bilateral labeling of the rVRGs, Bötzinger complex, gigantocellular reticular 
nucleus, nuclei of the tractus solitarius, raphe nuclei, and the vestibular nuclei (Boulenguez 
et al., 2007). Although the Fluorogold was injected into the phrenic nucleus and not injected 
intradiaphragmatically, Fluorogold still demonstrates the synaptic relationship between the 
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neurons at the level of the PN and medullary centers that coordinate respiration, including 
diaphragmatic function. Similarly, application of PRV, a transsynaptic neuronal tracer 
applied to the diaphragm or phrenic nerve in non-injured or acute C2Hx rats labels the 
ipsilateral PMNs, interneurons in laminae VII and X bilaterally, cervical interneurons in the 
dorsal horn bilaterally, and the rVRGs (Dobbins and Feldman, 1994; Lane et al., 2008). The 
comparison of various tracers resulting in different patterns of neuronal labeling emphasizes 
the importance of the WGA component of WGA-Alexa 488 that is responsible for the 
selective transport of the tracer across physiologically active synapses (Goshgarian and 
Buttry, 2014), similar to that of WGA-HRP (Harrison et al., 1984, 1986; Jankowska, 1985). 
The importance of the selectivity of WGA-Alexa 488 is further demonstrated when 
comparing the pattern of labeling in the spinal cord and medulla of acutely injured C2Hx 
rats versus chronically injured C2Hx rats. The application of WGA-Alexa 488 reveals injury 
induced plasticity that alters physiologically active connections within the respiratory motor 
pathways. 
Initially for the chronic sham model WGA-Alexa 488 was expected to be isolated to 
the PN and rVRGs since the hemisection of the cervical spinal cord was omitted. However, 
the chronic sham tissue displayed bilateral WGA-Alexa 488 labeled interneurons primarily 
in laminae VII and VIII of the cervical and thoracic cord and bilateral WGA-Alexa 488 labeled 
intercostal motoneurons in the thoracic spinal cord in addition to phrenic and rVRG labeled 
cells This implies that the sham C2Hx surgery including laminectomy of C2, durotomy, and 
laparotomy had an impact on the spinal cord environment. This is not surprising since the 
traumatic effects of a laminectomy and durotomy (without a hemisection) has been 
previously documented and is linked to pseudomeningocele, hypovolemia, activation of 
astroglia, herniation of the spinal cord and nerve roots, ischemia, scar tissue, and neuronal 
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cell death (Hadley and Goshgarian, 1997; He et al., 1995; Hershman et al., 2013; Hosono 
et al., 1995; Macki et al., 2014). In addition, laparotomy has been shown to depress 
respiration (Barbalho-Moulim et al., 2011; Sieck and Fournier, 1989). Any of the stated side 
effects or a combination of these effects has the potential to disrupt the normal spinal cord 
circuitry and provoke spinal plasticity. Interestingly, the sham surgical procedure induces 
changes only in the spinal cord. The supraspinal components of the phrenic motor pathway 
appear to be unaffected by the sham surgery based on the observation that WGA-Alexa 
488 labeling was restricted to the rVRG in the medulla in the sham rats. Therefore, implying 
a C2Hx must be carried out to induce supraspinal changes in the respiratory circuitry. 
In the chronically injured model, when rats are provided a survival time of at least 7 
weeks following a C2Hx, ipsilateral intradiaphragmatic injection of WGA-Alexa 488 followed 
by a 48-hour survival time results in the labeling of phrenic, intercostal and forelimb 
motoneurons, interneurons in the cervical and thoracic spinal cord, and the ipsilateral RST, 
DSCT, and VSCT. Comparison of the WGA-Alexa 488 labeling pattern in each experimental 
group suggests that the labeled neurons unique to the chronic C2Hx model (forelimb 
motoneurons, RST, DSCT, and VSCT) may participate in newly established or more likely 
strengthened synaptic connections to the diaphragm in response to the C2Hx. However, 
the anatomical data alone cannot confirm if the WGA-Alexa 488 labeled neurons unique to 
the chronic C2Hx rats are responsible for the time-associated functional recovery detected 
at the level of the diaphragm in 62% of the chronic C2Hx rats. Regardless, based on the 
WGA-Alexa 488 labeled nuclei and tracts in the spinal cord unique to the chronic C2Hx 
model, there is an undeniable difference of connectivity in the acute C2Hx model and 
chronic sham model compared to the chronic C2Hx model.  
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The WGA-Alexa 488 labeled neurons in the spinal cord of the chronically C2Hx rats 
are discussed as follows. Several motor nuclei throughout the cervical spinal cord were 
bilaterally labeled with WGA-Alexa 488 in addition to the motoneurons within the PN. 
Starting at the most rostral aspect and moving in the caudal direction, motor nuclei 
containing WGA-Alexa 488 labeled motoneurons that supply the triceps brachii, and the 
manus (hand) and/or forearm extensors were identified (Watson et al., 2009). As stated 
previously, at this time we cannot confirm the role of each neuronal cell type labeled in the 
chronic C2Hx spinal cord system. However, there is a physiological change in the synaptic 
connections as demonstrated by the selective transsynaptic transport of WGA-Alexa 488 
across physiologically active synapses in the acute C2Hx model and chronic sham model 
compared to the chronic C2Hx model. Based on previous work demonstrating reciprocal 
interactions between respiration and locomotion generators in the cervicothoracic cord 
(Viala and Freton, 1983), one potential role of forelimb motoneurons in the chronically C2Hx 
spinal cord could be increased involvement in the coordination of accessory respiratory 
muscles to aid in the maintenance of respiration while walking. The coordination of 
respiration while walking may become more critical in the chronically C2Hx rat, requiring 
additional feedback and corrective measures. This could account for the strengthening of 
existing synapses between the respiratory pathway and pathways involved in the 
coordination of respiration with motility.  
Continuing in the caudal direction, WGA-Alexa 488 labeling was located in the nuclei 
containing the intercostal motoneurons in the thoracic spinal cord of the chronic C2Hx rats 
and chronic sham rats. It has been established that intercostal motoneurons have existing 
connections to the rVRGs to coordinate respiration with movement of the intercostal 
muscles (Feldman et al., 1985; Hilaire and Monteau, 1997) in both the non-injured system 
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and following cervical spinal cord injury (Bellingham, 1999; Tian and Duffin, 1996). The 
appearance of WGA-Alexa 488 labeling in the intercostal motoneurons in the thoracic spinal 
cord of the chronic C2Hx rats and chronic sham rats suggests a modification to strengthen 
existing synapses in response to the trauma related to the surgical exposures, but not 
necessarily the hemisection. Another possibility is, because the hemidiaphragm is atrophied 
in the chronic C2Hx rats, the tracer could leak into the intrapleural cavity and directly label 
intercostal neurons. However, this would not explain intercostal neuron labeling in the 
chronic sham rats demonstrating spontaneous recovery in which the hemidiaphragm is not 
atrophied.  
In addition to motoneurons, three ipsilateral white matter tracts were identified with 
axons containing WGA-Alexa 488 in the chronically C2Hx rats. The RST, DSCT, and VSCT 
were identified based on their anatomical location in the ipsilateral funiculi; the tracts were 
consistently displayed in all chronic C2Hx rat spinal cords, but not in the chronic sham rats. 
The DSCT and VSCT are well established as the pathway to transmit information of 
unconscious proprioception of the ipsilateral trunk/thorax and lower/hind limb to the 
cerebellum (Bosco and Poppele, 2001; Matsushita and Gao, 1997; Soja et al., 1995; 
Stecina et al., 2013; Valle et al., 2000). VSCT neurons located in lamina VII have been 
shown to monitor activity of spinal interneuronal networks and descending commands to 
the spinal motoneurons and interneurons (Shrestha et al., 2012; Stecina et al., 2013). In 
addition, it has been demonstrated that a population of DSCT neurons located in the 
thoracic cord in laminae VII and VIII (Tanaka et al., 1990) carries information of chest wall 
movements to the cerebellum. Recordings from spinocerebellar tract neurons showed 
either rhythmic activity matching that of artificial ventilation or with phrenic nerve activity 
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demonstrating a role in feedback and reflex pathways (Hirai et al., 1988; Tanaka and Hirai, 
1994).  
In our chronically C2Hx model, the axons of the ipsilateral DSCT and ipsilateral 
VSCT were consistently labeled with WGA-Alexa 488, suggesting an increase in 
communication by the sensory tracts to relay information about the current state of the 
thoracic cavity's peripheral wall. Sensory information from the thoracic cavity could play a 
feedback role in the coordination of accessory muscles to aid in the compensation of the 
lost hemidiaphragm function. Vinit and Kastner (2009) suggested that after a chronic partial 
SCI, there is a strategy to by-pass the injury that will consist of redistribution and rewiring 
of the descending pathways within the spinal cord through the development of accessory 
pathways. Based on the WGA-Alexa 488 labeling present in the chronic C2Hx model, the 
DSCT and VSCT could be involved in a strategy to by-pass the injured pathway.  
The RST carries the primary descending bulbospinal respiratory pathway; RST 
axons had a scattered appearance throughout the lateral and ventromedial funiculi with the 
majority of the fibers terminating in the cervical enlargement (Feldman et al., 1985; Lipski 
et al., 1994; Nathan, 1963; Nathan et al., 1996; Peterson et al., 1975). Interestingly the RST 
was identifiable with WGA-Alexa 488 labeling in the chronically C2Hx model but was not 
easily detected in the acutely C2Hx model. A possible explanation to the WGA-Alexa 488 
detected in the reticulospinal axons could involve spinal hyper-reflexia that is documented 
in chronic (1–12 months) spinal cord injury patients. Spinal hyper-reflexia is caused by new 
synapse growth of long-axoned neurons or competitive and activity-dependent synapse 
growth (Ditunno et al., 2004). An increase in synaptic activity or an increase in the number 
of axons communicating respiratory impulses documented in spinal hyper-reflexia could 
account for the WGA-Alexa 488 labeling within the ipsilateral RST axons.  
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In the chronic C2Hx rats and chronic sham rats, WGA-Alexa 488 labeled 
interneurons were identified throughout the cervical and thoracic spinal cord. The 
interneurons were predominately located in laminae VII and VIII. Previous studies have 
presented data describing how spinocerebellar tract (DSCT and VSCT) neurons located in 
laminae VII and VIII convey information of the central respiratory generator (Matsushita and 
Gao, 1997; Qin et al., 2002; Tanaka et al., 1990). In addition, the role of interneurons in the 
non-injured or injured spinal cord, specifically within the phrenic motor system involving 
communication between the medullary respiratory centers and/or the right and left PN have 
been considered (Darlot et al., 2012; Dougherty et al., 2012a, 2012b; Lane et al., 2008; 
Lipski et al., 1993; Qin et al., 2002; Saywell et al., 2011). In this study, WGA-Alexa 488 
labeled interneurons in the chronic C2Hx and chronic sham spinal cord compared to the 
complete lack of interneurons in the acutely C2Hx spinal cord demonstrates injury induced 
plasticity that may alter the synaptic function in the chronic C2Hx and chronic sham spinal 
cord environment. However, the precise contribution of interneurons remains unclear and 
requires further investigation to gather precise details in respect to respiratory function and 
the role of interneurons. 
WGA-Alexa 488 labeling in the medulla of acutely C2Hx rats compared to the 
medulla of chronically C2Hx rats demonstrates injury-induced supraspinal plasticity that 
may alter physiologically active synapses within the medulla. Following intradiaphragmatic 
injection of WGA-Alexa 488, the acute C2Hx model (and sham) demonstrates isolated 
WGA-Alexa 488 labeling of the rVRGs bilaterally. However, in the chronic C2Hx model in 
addition to the rVRGs, raphe, hypoglossal, spinal trigeminal, parvicellular reticular, 
gigantocellular reticular, and intermediate reticular nuclei, which importantly have all been 
demonstrated previously to be associated with respiratory control in acutely hemisected or 
41 
 
non-injured rats, were consistently labeled bilaterally with WGA-Alexa 488. The labeled 
nuclei and possible respiratory-based interactions of these nuclei in the chronic C2Hx model 
are as follows. 
Raphe neurons were identified along the midline of the medulla. Midline 
serotonergic raphe neurons are associated with respiration by influencing respiratory 
associated nuclei including the hypoglossal, rVRGs, and PN (Manaker et al., 1992; Barker 
et al., 2009; Richerson, 2004 for review). Raphe neurons, rVRG connections to the 
trigeminal, and to the gigantocellular nuclei could have a possible role in spontaneous 
recovery in the chronically C2Hx model based on the presence of WGA-Alexa 488. All of 
the previously listed nuclei have been described as having synaptic connections to one 
another (Dobbins and Feldman, 1994; Gaytán and Pásaro, 1998). In addition, it has been 
demonstrated that neurons within the gigantocellular nuclei innervate the hypoglossal 
(Yang et al., 1995) and have a connection to the C3–C4 region of the spinal cord 
(Boulenguez et al., 2007). Golder et al. (2001a) suggested supraspinal plasticity two months 
after spinal hemisection based on an altered response in hypoglossal motor output; rVRG 
respiratory premotor collaterals have been shown to project to the hypoglossal in addition 
to the PN (Lipski et al., 1994).  
The parvicellular reticular nuclei (PRN) were labeled in the chronic C2Hx model and 
links the function of all of the additional WGA-Alexa 488 labeled nuclei together. The PRN 
contains pre-motor neurons with direct projections to the trigeminal that affect motor 
behavior of the jaw (orofacial motor control) (Notsu et al., 2008; Nozaki et al., 1993; Sahara 
et al., 1996). In addition, the PRN are a source of pre-motor neurons with projections to the 
hypoglossal (Shammah-Lagnado et al., 1992), to the intermediate reticular nucleus 
(laryngeal function Simonyan et al., 2012), and the gigantocellular among others to control 
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jaw and tongue movement during facial movements including those associated with 
respiration (Luo et al., 2006; Mogoseanu et al., 1993; Ter Horst et al., 1991; Travers and 
Norgren, 1983; Tsumori et al., 2010; Yasui et al., 2004; Zhang and Luo, 2003). Afferents to 
the PRN communicate information from sensory structures related to orofacial and 
gustatory control, including sensory information regarding respiration (Fay and Norgren, 
1997; Minkels et al., 1991; Mogoseanu et al., 1993; Ter Horst et al., 1991; Yasui et al., 
2004). These connections demonstrate the established neuroanatomical framework in a 
non-injured system for the participation of the medullary nuclei in respiration that appears 
to be in a hyperactive state based on the pattern of WGA-Alexa 488 in the chronically C2Hx 
model.  
The exact role of each medullary center in respect to spontaneous recovery of 
hemidiaphragm function following a C2Hx is far from being completely understood. The use 
of WGA-Alexa 488 as a neuronal tracer to detect changes in physiologically active synapses 
post injury provides a valuable tool to identify areas of plasticity. The labeled nuclei provided 
a starting point to examine the chronic effects of a C2Hx and possible targets for intervention 
to regain functional abilities. 
WGA-Alexa transsynaptic labeling in the phrenic motor system of adult rats: 
Intrapleural injection versus intradiaphragmatic injection  
 
Injection of WGA-Alexa 488 into the diaphragm consistently labels cell populations 
involved in the innervation of the diaphragm. Unfortunately, intradiaphragmatic injection 
requires a laparotomy, an invasive surgical exposure, shown to adversely affect respiration, 
therefore potentially altering functional outcomes (Sieck and Fournier, 1989; Barbalho-
Moulim et al., 2011). In 2009 Mantilla and colleagues introduced a new method of labeling 
PMNs by injecting cholera toxin subunit beta (CTB) conjugated to Alexa 488 bilaterally into 
the intrapleural space. Delivery of a retrograde neuronal tracer by way of intrapleural 
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injection to label the phrenic motor system eliminates the need for anesthesia and the 
laparotomy required for intradiaphragmatic injections (Mantilla et al. 2009). Following 
intrapleural injection the authors reported labeling of PMNs as well as thoracic intercostal 
motoneurons and dorsal root ganglion neurons, but there was no evidence of transsynaptic 
labeling within the spinal cord tissue examined (Mantilla et al., 2009).  
When investigating anatomical changes of the respiratory motor pathway following 
spinal cord injury, both the pre-motor neurons in the rVRGs that are responsible for 
descending respiratory drive as well as the motoneurons in the PN must be considered. 
Mantilla and colleagues (2009) did not report any evidence of transsynaptic transport in the 
medulla presumably because CTB-Alexa 488 is not a transsynaptic tracer (Cabot et al., 
1994, Lee et al., 2009). Therefore, the possibility of transsynaptic transport of a neuronal 
tracer to the rVRGs in the medulla following intrapleural injection is still a question that has 
yet to be resolved.  
The first aim of this study was to inject WGA-Alexa 488, a known retrograde 
transsynaptic tracer (Goshgarian and Buttry, 2014) into the intrapleural space to determine 
if transsynaptic labeling would occur. In carrying out this experiment we found it necessary 
to differentiate rVRG neurons from nucleus ambiguus (NA) neurons. The neurons of these 
two nuclei are intermingled in the ventrolateral medulla (Feldman and Ellenberger, 1988; 
Ellenberger and Feldman, 1990a, 1990b; Hayakawa et al., 2004; Spyer, 2009) and it is 
difficult to differentiate a rVRG neuron from a NA neuron by morphology alone. The 
identification of WGA-Alexa 488 labeled rVRG neurons would suggest retrograde 
transsynaptic labeling from the phrenic nuclei to the rVRG following intrapleural injection. 
However, since the NA innervates some targets in the thoracic cavity via the vagus nerve 
(lung parenchyma, Hadziefendic and Haxhiu, 1999; bronchus, Fontán et al., 2000; trachea, 
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Pérez Fontán and Velloff, 2001), this potential route of tracer uptake following intrapleural 
injection must be considered. Exposure of the vagus nerve or vagal nerve targets to WGA-
Alexa 488 following intrapleural injection resulting in the labeling of NA cells would indicate 
retrograde labeling (not transsynaptic labeling). To identify the cell bodies that contribute to 
the vagus nerve, True blue, a retrograde tracer incapable of crossing synapses can be 
injected directly into the vagus nerve (Payne, 1987). The second aim of this study therefore 
was to differentiate labeled neurons identified as rVRG cells and NA cells. Three different 
tracers injected into three different locations were used to determine the extent of retrograde 
transsynaptic transport following intrapleural injection. 
Several combinations of injections were administered to non-injured rats as detailed 
in Table 2. The various combinations were chosen to ensure the results were due to the 
location of the injections and not the injected substances themselves.  
 
Table 2: The 11 rats included in the intrapleural study and the locations and tracers 
injected into each rat. Column 1 lists the Animal Identification. Column 2 lists the weight 
at the time of injection for each rat. Columns 3–5 list the tracers injected into each location. 
Columns 6 & 7 notes the anatomical plane the medulla and spinal cord tissue samples were 
sectioned. Buttry and Goshgarian, 2015. 
Results  
45 
 
Injection of WGA-Alexa 488 (green) into the right intrapleural cavity resulted in 
retrograde transport to produce bilateral labeling of PMNs in the cervical spinal cord (C3 – 
C6) in 7 of the 9 rats (Fig. 21A, 21E, Table 3). The remaining 2 rats lacked WGA-Alexa 488 
labeling following intrapleural injection in all spinal sections examined. Lack of labeling in 
the 2 rats was likely due to an injection directly into the lung parenchyma, not the intrapleural 
space. At the time of perfusion, the 2 rats that lacked labeling displayed a site of trauma on 
the right upper portion of the lung and the lung tissue was notably yellow, the color of WGA-
Alexa 488 in saline solution. Due to this observation, the 2 rats; TB4 and TB6, were 
excluded from quantitative analysis.  
 
Table 3: Cell counts from 270 cervical spinal cord sections sampled from 5 rats. 
Column 1 lists the ID for each rat. Rats that received both intradiaphragmatic and 
intrapleural injections were included in this cell count. Column 2 lists the number of WGA-
Alexa 594 labeled cells located in the right phrenic nucleus (PN). Column 3 lists the number 
of WGAAlexa 488 labeled cells located in the right PN. Column 4 lists the number of dually 
labeled cells with WGAAlexa 594 and WGA-Alexa 488 located in the right PN. Column 5 
lists the number of WGA-Alexa 594 labeled cells located in the left PN. Column 6 lists the 
number of WGA-Alexa 488 labeled cells located in the left PN. Column 7 lists the number 
of dually labeled cells with WGA-Alexa 594 and WGA-Alexa 488 located in the left PN. 
Columns 8–10 list the total number of cells  (right and left sides combined) labeled with 
WGA-Alexa 594, WGAAlexa 488, or with a dual label of WGA-Alexa 594 and 488 
respectively. The TB3 spinal cord was sectioned in a sagittal plane, left could not be 
differentiated from right therefore only total counts were recorded. TB1 was excluded from 
the count due the animal not receiving an intradiaphragmatic injection. TB4 and TB6 were 
excluded due to an unsuccessful intrapleural injection. Buttry and Goshgarian, 2015. 
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Intradiaphragmatic injection of WGA-Alexa 594 (red, N=8) or WGA-Alexa 488 
(green, N=2) into the left hemidiaphragm also resulted in bilateral labeling of PMNs in all 
rats examined (Fig. 21A, 21E). At the level of the phrenic nuclei (C3 – C6), both intrapleural 
and intradiaphragmatic injection resulted in isolated labeling throughout the phrenic nuclei 
in all cervical spinal cord sections examined. There was no labeling in any other neuronal 
center at C3 – C6 (Fig. 21, 22). Moreover, there was no evidence of spinal interneurons 
labeled with either WGA-Alexa 488 or 594 following intrapleural or intradiaphragmatic 
injection. The lack of spinal interneurons confirms the findings in our previous studies 
examining WGA-Alexa 488 labeling following intradiaphragmatic injection (Goshgarian and 
Buttry, 2014; Buttry and Goshgarian, 2014). Of the WGA-Alexa 488 labeled cells observed 
in the PN following a right intrapleural injection, 86 ± 17.9% displayed a dual label with 
WGA-Alexa 594 (left intradiaphragmatic injection) (Table 3). This data confirms that 
intrapleural injection is an effective method to label PMNs and is comparable to 
intradiaphragmatic injection (Mantilla et al., 2009). In addition, following intrapleural injection 
WGA-Alexa 488 was detected bilaterally in the thoracic spinal cord in the intercostal motor 
nuclei (Fig. 23A) confirming the findings of Mantilla and colleagues (2009). However, 
following intradiaphragmatic injection, neither WGA-Alexa 594 (red, N=8) or WGA-Alexa 
488 (green, N=2) were detected in the thoracic spinal cord (Fig. 23B) confirming the results 
of our previous study (Buttry and Goshgarian, 2014). The labeling of intercostal 
motoneurons following intrapleural injection, but not after intradiaphragmatic injection 
indicates that the tracer is exposed to phrenic axons exclusively when injected into the 
diaphragm (Buttry and Goshgarian, 2014). In contrast, intrapleural injection results in the 
tracer being exposed to the entire intrapleural space, in which the tracer is able to diffuse 
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freely before coming into contact with multiple muscle targets including the diaphragm and 
intercostal muscles.  
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Figure 21: Transverse sections of the cervical spinal cord at the level of the phrenic 
nuclei in the same rat following intrapleural and intradiaphragmatic injection. A. 
displays a low magnification of the left phrenic nucleus (encircled), B-D display a higher 
magnification of A. B displays WGA-Alexa 488 (green filter) labeled cells following a right 
(contralateral) intrapleural injection of this tracer. C displays WGA-Alexa 594 (red filter) 
labeled cells following a left (ipsilateral) intradiaphragmatic injection. D is a merged image 
of B and C; note cells contain either WGA-Alexa 488 (arrow) or 594 alone (θ arrow), or a 
mixture of both tracers (noted with *in the nucleus). The dually labeled cells are easily 
identified in B and C. E displays a low magnification of the right phrenic nucleus (encircled), 
F-H display a higher magnification of E. F displays WGA-Alexa 488 (green) labeled cells 
following a right (ipsilateral) intrapleural injection. G displays WGA-Alexa 594 (red) labeled 
cells following a left (contralateral) intradiaphragmatic injection. H is a merged image of F 
and G; note cells contain either WGA-Alexa 488 (arrows) or a mixture of both tracers (noted 
with * in the nucleus). Scale bars are 200μm (A and E) and 50μm (BD and F-H). Buttry and 
Goshgarian, 2015. 
 
 
Figure 22: Sagittal section through the cervical spinal cord following intrapleural and 
intradiaphragmatic injection (insert of transverse section for reference). WGA-Alexa 488 
(green filter) and WGA-Alexa 594 (red filter) labeling within the right phrenic nucleus 
following right intrapleural injection of WGA-Alexa 488 and left intradiaphragmatic injection 
of WGA-Alexa 594. Notice cells contain either WGA-Alexa 488 (green, examples noted with 
# arrow) or WGA-Alexa 594 (red, examples noted with θ arrow) and cells with a dual label 
appear yellowish in color (examples noted with * arrows). Scale bar is 100μm. Buttry and 
Goshgarian, 2015. 
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The first rat analyzed to validate if intrapleural injection was able to produce spinal 
cord and medullary labeling with WGA-Alexa 488 received a right intrapleural injection of 
WGA-Alexa 488 followed by an injection of True blue into the right vagus nerve. Forty-eight 
hours after injection the rat was sacrificed and the tissue was sectioned. The tissue samples 
from the medulla demonstrated labeled cells in the intermingled region of the NA and rVRG. 
Some cells were labeled with either WGA-Alexa 488 or True blue (Fig. 24). In addition, there 
were numerous cells dually labeled with both WGA-Alexa 488 and True blue demonstrating 
that intrapleural injection results in the labeling of NA cells. 
 
 
Figure 23:  T6 spinal cord section following intrapleural and intradiaphragmatic 
injection. A, Low power magnification of a transverse section through the spinal cord at the 
T6 level showing bilateral WGA-Alexa 488 (green filter) labeling in the region of the 
intercostal motor nuclei (encircled areas) following right intrapleural injection of this tracer. 
B, image of the same section in A using the red filter to detect WGA-Alexa 594 following left 
intradiaphragmatic injection. The WGA-Alexa 594 label (red) is absent (encircled areas). 
Thus, intrapleural injection labels intercostal motoneurons, but Intradiaphragmatic injection 
does not. Scale bar is 200μm. P; pinhole marks left side. Buttry and Goshgarian, 2015. 
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Figure 24: High magnification of the NA and rVRG following intrapleural injection and 
vagus nerve injection. This rat received a right intrapleural injection of WGA-Alexa 488 
(green) followed by an injection of True blue into the right vagus nerve (blue). The merged 
image demonstrates the intermingled relationship between the two labeled cell populations. 
Some cells are labeled with either WGA-Alexa 488 or True blue as well as cells dually 
labeled with both WGA-Alexa 488 and True blue (noted with * in the nucleus) demonstrating 
that intrapleural injection results in the labeling of NA cells. 
 
To further investigate the route of tracer uptake by the NA cells, 8 rats were injected 
with 3 types of tracer in 3 different locations (Table 2). Six of the 8 rats that received 3 
tracers displayed individually labeled, dual labeled and triple labeled cells in the region of 
the rVRG and NA (Fig. 25-27, Table 4). TB4 and TB6 were excluded due to the lack of 
WGA-Alexa 488 labeling in the spinal cord as mentioned previously. The following 
qualitative and quantitative data includes a total of 82 sections spanning the medulla from 
6 rats (summary in Table 4). The left half of the medulla displayed WGA-Alexa 488 and 
WGA-Alexa 594 labeling isolated to the rVRG and NA following right intrapleural (WGA-
Alexa 488) and left intradiaphragmatic (WGA-Alexa 594) injection. Of these cells 18.1 ± 
10.8% were observed with only WGA-Alexa 488 (green filter, Fig. 25A), 13.6 ± 7.1% with 
only WGA-Alexa 594 (red filter, Fig. 25B), and 68.2 ± 8.9% were dually labeled with both 
tracers (yellow in appearance, Fig. 25D). Left intradiaphragmatic injection of WGA-Alexa 
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594 resulted in uptake of the tracer by the phrenic nerve, retrograde transport to the phrenic 
nuclei, followed by transsynaptic transport to the rVRGs as demonstrated in our previous 
study investigating WGA-Alexa 488 (Goshgarian and Buttry, 2014). Cells containing WGA-
Alexa 488 following intrapleural injection were labeled by one or more of the following three 
potential routes; 1) transsynaptic transport following tracer uptake by the phrenic nerve, 2) 
transsynaptic transport following tracer uptake by the intercostal nerves, or 3) retrograde 
transport following tracer uptake from the vagus nerve and its extensive branches that 
innervate targets in the thoracic cavity. It is important to note that there was a complete 
absence of True blue in the left half of the medulla following True blue injection into the right 
vagus nerve (Fig. 25C).   
 
Table 4: Cell counts from a total of 82 medulla sections sampled from 6 rats. Column 
1 lists the ID for each rat. Rats that received injections in all three locations 
(intradiaphragmatic, intrapleural and vagus nerve) were included in this cell count. Columns 
2–8 list the numbers of labeled cells located in the right half of the medulla in the region of 
the NA and rVRG. Cells were identified as individually labeled (WGA-Alexa 594, WGA-
Alexa 488, or True blue), dually labeled (any combination of 2 of the 3 tracers), or triple 
labeled (all 3 tracers in a single cell). Columns 9–11 list the numbers of labeled cells located 
in the left half of the medulla in the region of the NA and rVRG. Cells were identified as 
individually labeled (WGA-Alexa 594 or WGA-Alexa 488), or dually labeled with both WGA-
Alexa 594 and WGA-Alexa 488. TB1 was excluded from the count due the animal not 
receiving an intradiaphragmatic injection. TB4 and TB6 were excluded due to an 
unsuccessful intrapleural injection. Buttry and Goshgarian, 2015. 
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Figure 25: High magnification of the NA and rVRG following intrapleural, 
intradiaphragmatic and vagus nerve injection. High power magnification of a transverse 
section through the medulla displaying both the left (A-D) and right (E-H) rostral ventral 
respiratory groups and the nucleus ambiguus. A and E display WGA-Alexa 488 (green filter) 
labeled cells following a right intrapleural injection of this tracer (A and E captured with equal 
exposure times). B and F display WGA-Alexa 594 (red filter) labeled cells following a left 
intradiaphragmatic injection of this tracer (B and F captured with equal exposure times). C 
and G display the absence on the left and presence on the right of True blue (blue filter) 
labeled cells following a right vagus nerve injection of this tracer (C and G captured with 
equal exposure times). D is a merged image of A-C, notice cells contain either WGA-Alexa 
488 (green, θ arrow), WGA-Alexa 594 (red, # arrow), or a dual label and appear yellow in 
color (noted with * in the nucleus). All rVRG cells are transsynaptically labeled. The image 
shows that not all rVRG cells are dually labeled; some are green only and some are red 
only. H is a merged image of E-G. Notice cells contain either True blue alone (nucleus 
ambiguus cells, ℧ arrow) or a mixture of two or three of the labels in one cell. The yellow 
cells are dually labeled rVRG cells (WGA-Alexa 488 and WGA- Alexa 594, arrow), but the 
dually (True blue and WGA-Alexa 594, # arrow) and triple labeled cells (noted with * in the 
nucleus) suggests that rVRG and NA cells not only intermingle, but they have a synaptic 
relationship. The cells marked with an asterisk in H can be seen with the green, red and 
blue filter in E-G respectively. Scale bar is 50μm. Buttry and Goshgarian, 2015. 
 
In comparison, the right half of the medulla displayed WGA-Alexa 488 and WGA-
Alexa 594 labeling isolated to the rVRG and NA (Fig. 25–27) following intrapleural (WGA-
Alexa 488) and intradiaphragmatic (WGA-Alexa 594) injection. A total of 189 cells were 
identified as rVRG neurons based on the presence of WGA-Alexa 488 alone, WGA-Alexa 
594 alone, or a dual label of 488 and 594 and a complete absence of True blue. Of the right 
rVRG cells, 9.2 ± 8.6% were observed with WGA-Alexa 488 (green filter, Fig. 25E), 9.3 ± 
6.9% with WGA-Alexa 594 (red filter, Fig. 25F), and 81.5 ± 11.8% were dually labeled with 
both WGA-Alexa 488 and WGA-Alexa 594 (yellow in appearance, Fig. 25H). However, 
unique to the right half of the medulla, True blue (TB) a retrograde tracer incapable of 
crossing synapses (Payne, 1987) was injected into the right vagus nerve to identify the 
ipsilateral NA cells (Fig. 25G & H). A total of 1026 NA cells contained TB. Of these NA cells, 
65.9 ± 15.4% contained TB alone, 3.0 ± 3.5% contained TB with WGA-Alexa 594, 5.1 ± 
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5.1%) contained TB with WGA-Alexa 488, and 26.0 ± 9.7% contained all three tracers (Fig. 
25H, 26D, 27). In addition to the right NA, TB alone was identified in a scattering of cells 
ventral to the NA (Fig. 26C, 26D, & 27), and in the dorsal motor nucleus of vagus (DMX) 
(Fig. 28), both isolated to the right side. The anatomical relationship of the rVRG and NA 
can be appreciated in both transverse (Fig. 25 & 27) and sagittal (Fig. 26) planes where 
both nuclei intermingle within the same cell column in the ventrolateral medulla as described 
previously (Feldman and Ellenberger, 1988; Ellenberger and Feldman, 1990a, 1990b; 
Hayakawa et al., 2004; Spyer, 2009).  
To validate the result of identifying WGA-Alexa 594 in True blue labeled NA cells 
following intradiaphragmatic injection, two additional rats, NA1 and NA2 were added. True 
blue has a hazy appearance and can produce difficulties when examining tissue at the 
cellular level with a fluorescent microscope. In contrast WGA-Alexa fluorochromes have a 
distinct granulation resulting in easily identifiable labeled cells. NA1 and NA2 received right 
vagus nerve injections of WGA-Alexa 594 followed by left intradiaphragmatic injections of 
WGA-Alexa 488. Both rats displayed individually labeled cells of either WGA-Alexa 594 or 
WGA-Alexa 488, and dually labeled cells (Fig. 29). This again validates that 
intradiaphragmatic injection of WGA-Alexa fluorochromes results in both rVRG and NA 
labeled cells. 
Following intradiaphragmatic injection of WGA-Alexa 594, the observation of NA 
cells containing both TB and WGA-Alexa 594 suggests that WGA-Alexa 594 was 
transsynaptically transported from rVRG neurons to NA neurons. It is important to stress 
that this is the first anatomical report of a direct synaptic relationship between rVRG and  
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Figure 26: Sagittal section of the medulla displaying the right rVRG and the 
intermingled cells of the right NA. A displays WGA-Alexa 488 (green filter) labeled cells 
following a right (ipsilateral) intrapleural injection of this tracer. B displays WGA-Alexa 594 
(red filter) labeled cells following a left (contralateral) intradiaphragmatic injection. C 
displays True blue (blue filter) labeled cells following a right (ipsilateral) vagus nerve 
injection. D is a merged image of A-C, note that the blue labeled NA cells (arrows) not only 
follow the main column of the rVRG, but there is also a scattering of cells ventral to the main 
nuclei (arrows in C and D). Note also that many of the cells in the main column are dually 
labeled rVRG cells (WGA-Alexa 488 and WGA-Alexa 594, # arrows) or triple labeled NA 
cells (* arrows) demonstrating a synaptic relationship with the rVRG and NA cells. The 
ventrally extended cells (arrows in C and D) displayed only True blue label. Scale bar is 
200μm. Buttry and Goshgarian, 2015. 
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Figure 27: NA and rVRG and ventrally extended cells following intrapleural, 
intradiaphragmatic and vagus nerve injection. High power magnification of a transverse 
section through the medulla displaying the right rostral ventral respiratory group and the 
nucleus ambiguus (encircled) labeled after an ipsilateral intrapleural injection of WGA-Alexa 
488 (green filter) and a contralateral intradiaphragmatic injection of WGA-Alexa 594 (red 
filter). True blue (blue filter) was injected into the ipsilateral vagus nerve to label the NA. 
The figure is a merged image of all three tracers; notice cells contain either True blue alone 
(NA cells; cells without arrows within the encircled area) or a mixture of two or three of the 
labels in one cell (# arrow, True blue and WGA-Alexa 594; θ arrow, True blue and WGA-
Alexa 488; * arrow, triple label). Notice ventrally extended cells (arrows for examples), 
displaying True blue only, extend far ventral to the encircled NA and rVRG nuclei. Scale bar 
is 100μm. Buttry and Goshgarian, 2015. 
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Figure 28: Dorsal medulla following vagus nerve injection. Low power magnification of 
a transverse section through the dorsal medulla displaying the right dorsal motor nuclei of 
vagus (DMX) labeled with True blue (blue filter) after ipsilateral injection of True blue into 
the vagus nerve. A displays a complete lack of WGA-Alexa 488 (green filter) labeled cells 
following a right (ipsilateral) intrapleural injection of this tracer. B displays a complete lack 
of WGA-Alexa 594 (red filter) labeled cells following a left (contralateral) intradiaphragmatic 
injection. C displays True blue (blue filter) labeled cells within the right DMX (arrow) 
following a right (ipsilateral) vagus nerve injection. D is a merged image of A-C. Notice 
WGA-Alexa 488 and 594 labeling is completely absent in the DMX. IV notes the 4th ventricle 
for reference. Scale bar is 500μm. Buttry and Goshgarian, 2015. 
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Figure 29: NA and rVRG following vagus nerve injection and intradiaphragmatic 
injection. High magnification of the medulla in the area of the NA and rVRG. This rat 
received right vagus nerve injections of WGA-Alexa 594 followed by left intradiaphragmatic 
injections of WGA-Alexa 488. Both rats displayed individually labeled cells of either WGA-
Alexa 594 or WGA-Alexa 488, and dually labeled cells (noted with * in the nucleus). This 
again validates that intradiaphragmatic injection of WGA-Alexa fluorochromes results in 
both rVRG and NA labeled cells. 
 
select NA cells. Further support of the selectivity of this synaptic relationship is the 
observation that all other locations of TB labeled cells, i.e. the DMX (Fig. 28) and the cells 
scattered ventral to the main column of the NA and rVRG (Fig. 26C, 26D, and 27) had a 
complete lack of WGA-Alexa 594. Similar to intradiaphragmatic injection of WGA-Alexa 594, 
following intrapleural injection WGA-Alexa 488 was also absent in the DMX and in the 
region ventral to the NA suggesting that WGA-Alexa 488 was transsynaptically transported 
from the PN to the rVRG and then to only select cells of the NA. 
Discussion  
In 2009, Mantilla and colleagues demonstrated retrograde transport of CTB-Alexa 
488 to PMNs and intercostal motoneurons after intrapleural injection, but there was no 
evidence of transsynaptic transport. This study demonstrated that intrapleural injection of 
WGA-Alexa fluorochromes not only labels PMNs and intercostal motoneurons similar to 
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CTB-Alexa 488 (Mantilla et al., 2009), but is also transsynaptically transported in a 
retrograde fashion to the rVRG and select NA cells in the medulla.  
The rVRG and NA have been described as an intermingled column of neurons in 
the ventrolateral medulla indistinguishable based on size or morphology (Feldman and 
Ellenberger, 1988; Ellenberger and Feldman, 1990; Hayakawa et al., 2004; Spyer, 2009). 
In order to distinguish the NA from the rVRG, True blue, a retrograde tracer incapable of 
crossing synapses, was injected into the right vagus nerve (Sawchenko and Swanson, 
1981a, 1981b; Stuesse and Powell, 1982; Cunningham and Sawchenko, 1989). Following 
intrapleural injection, WGA-Alexa 488 was identified in both the rVRG and select NA cells. 
Right rVRG neurons were identified based on a dual label of WGA-Alexa 488 (intrapleural 
injection) and WGA-Alexa 594 (intradiaphragmatic injection) and a complete absence of TB 
(vagus nerve injection). NA cells were identified by TB labeling. Dual labeling of WGA-Alexa 
488 (intrapleural injection) and TB was also identified. There are two potential mechanisms 
as to how the NA cells became labeled with WGA-Alexa fluorochromes following 
intrapleural injection; by retrograde transport via targets of the vagus nerve in the thoracic 
cavity or transsynaptic transport via the phrenic motor pathway. 
Based on the observed locations of TB labeling, the latter mechanism is more 
probable. Following intrapleural injection of WGA-Alexa 488, select cells of the NA were 
labeled with WGA-Alexa 488 after transsynaptic transport within the phrenic motor pathway 
from the PN to the rVRG and subsequently to the NA. In support, WGA-Alexa 488 labeling 
was restricted to specific NA cells intermingled with rVRG cells. WGA-Alexa 488 was never 
identified in the other two locations of TB labeling: the DMX and the cells scattered ventral 
to the NA. 
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Following TB injection into the right vagus nerve, the right DMX and a scattering of 
cells ventral to the right NA were labeled with TB in addition to the right NA. The DMX has 
been shown to provide preganglionic parasympathetic innervation to the esophagus 
(Hadziefendic and Haxhiu, 1999; Hayakawa et al., 2002), larynx (Basterra et al., 1987; 
Kobler et al., 1994), trachea (Haxhiu and Loewy, 1996; Atoji et al., 2005), lung parenchyma 
(Hadziefendic and Haxhiu, 1999), and myocardium (Stuesse and Powell, 1982). The cells 
ventral to the NA are associated with the myocardium (Stuesse and Powell, 1982). These 
cells of the DMX and the area ventral to the NA are not related directly to respiration. If the 
only route of WGA-Alexa 488 transport to the NA was via uptake by the vagus nerve, the 
DMX and cells ventral to the NA would also be expected to exhibit a dual label of TB and 
WGA-Alexa 488. However, in all rats WGA-Alexa 488 was isolated to the rVRG and the 
intermingling cells of the NA demonstrating a functional significance of the transsynaptic 
transport of WGA-Alexa 488 from rVRG to select NA cells. Using physiological techniques, 
Ellenberger and Feldman (1990) demonstrated that some of the NA cells intermingled with 
the rVRG cells exhibit respiratory related discharge patterns. Previous studies demonstrate 
the selective characteristic of WGA-Alexa 488 to be transsynaptically transported over 
select physiologically active synapses of the respiratory motor pathway as compared in 
acute and chronic spinal cord injured rats (Buttry and Goshgarian, 2014). Following 
intradiaphragmatic injection of WGA-Alexa 488 into acutely C2Hx rats, the tracer was 
described as being located strictly in the PN and rVRG (Goshgarian and Buttry, 2014; Buttry 
and Goshgarian 2014). However, this study demonstrates the transsynaptic transport of 
WGA bound conjugates following intradiaphragmatic (as well as intrapleural) injection must 
be expanded beyond the rVRG to select cells of the NA in the non-injured rat. The 
connections between the NA and the rVRG have been described physiologically before 
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(Shannon and Freeman, 1981) and suggest a role in the coordination of respiration with 
muscle control over airflow (Ellenberger and Feldman, 1990; Spyer, 2009) mediated by 
pharyngeal and laryngeal muscles. Past studies speculated a role of interneurons relaying 
information between the NA and rVRG (Ellenberger and Feldman, 1990). However, based 
on the lack of interneuron labeling, this study provides anatomical evidence of a direct 
synaptic relationship between rVRG and select NA cells which further supports the 
contention that transsynaptic transport occurs over physiologically active connections. 
Moreover, this study demonstrates that transsynaptic transport of WGA-Alexa 
fluorochromes can occur over two synaptic connections linking PMNs with rVRG cells and 
subsequently select NA cells.  
Closing Statement 
 The results presented in Chapter 1 demonstrate that WGA-Alexa fluorochromes can 
be administered by means of intradiaphragmatic or intrapleural injection to selectively 
identify physiologically active connections between motor and pre-motor neurons in the 
respiratory circuitry. The importance of the selectivity of WGA-Alexa 488 is undoubtedly 
demonstrated when comparing the pattern of labeling in the spinal cord and medulla of 
acutely injured C2Hx rats versus chronically injured C2Hx rats. WGA-Alexa 488 reveals 
injury induced plasticity that alters physiologically active connections within the respiratory 
motor pathways detectable just weeks after injury. As a result, these studies provide 
investigators with a new method that eliminates the need of chemical reactions, to examine 
plasticity in the respiratory system after spinal cord injury. In addition, the differences 
between WGA-Alexa 488 labeling in the acutely vs. chronically injured system provide an 
extensive list of nuclei that can be investigated further to determine their role in recovery of 
the diaphragm. Depending on an investigator’s needs, either intrapleural or 
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intradiaphragmatic injection proves to be an easily executed and dependable method to 
label neurons in the respiratory circuitry. Moreover, the application of WGA-Alexa 
fluorochromes may provide useful in investigating anatomy prior to and following injury to 
other motor systems. 
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CHAPTER 2: RECOVERY OF DIAPHRAGM FUNCTION IN THE ACUTELY INJURED 
SPINAL CORD MODEL USING A RETROGRADE TRANSSYNAPTIC THEOPHYLLINE 
BOUND NANOCONJUGATE 
 
Summary 
 The primary descending respiratory drive, provided by the bulbospinal pathway, 
transmits an excitatory impulse from the rostral Ventral Respiratory Groups (rVRGs) in the 
medulla to the phrenic nuclei (PN) in the cervical spinal cord. The PN then stimulates the 
diaphragm via the phrenic nerves, resulting in contraction of the diaphragm during 
inspiration. Following a spinal cord hemisection at the second cervical segment (C2Hx) the 
ipsilateral hemidiaphragm is paralyzed due to the disruption of the rVRG axons descending 
to the ipsilateral phrenic nucleus. Systemically administered theophylline activates a 
functionally latent crossed phrenic pathway (CPP) which decussates caudal to the 
hemisection, activating phrenic motoneurons ipsilateral to the hemisection. The result is 
return of function to the paralyzed hemidiaphragm. Unfortunately, in humans systemically 
administered theophylline at a therapeutic dose produces many unwanted side effects. In 
order to eliminate the side effects of theophylline while still maintaining the ability to 
stimulate the CPP, a tripartite nanoconjugate was synthesized in which theophylline was 
bound to a neuronal tracer, WGA-HRP, using gold nanoparticles (AuNPs) as the coupler. 
Following intradiaphragmatic injection of the nanoconjugate, WGA-HRP selectively targets 
the nanoconjugate to phrenic motoneurons initially and then to the premotor neurons in the 
rVRG by transsynaptic transport. The ester bond between theophylline and AuNP degrades 
following injection, releasing theophylline. This method of targeted drug delivery results in 
a return of function to the once paralyzed hemidiaphragm.   
Introduction 
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 According to the National Spinal Cord Injury Statistical Center (NSCISC, 
2015) the number of people in the United States affected by SCI who were alive in 2014 is 
estimated to be approximately 276,000, (range of 240,000 to 337,000). The life span 
expectancy of these individuals after SCI is greatly reduced when the patient is ventilator 
dependent (NSCISC, 2015). The reduced life span is due to the fact that respiratory system 
complications are a major cause for re-hospitalization and death. The reported leading 
causes of death for individuals with a SCI are pneumonia, septicemia, other diseases of the 
respiratory system, and cardiovascular diseases (NSCISC, 2015, Yang et al., 2015). 
Increasing a patient’s respiratory output with pharmacological intervention could lead to 
eliminating ventilator dependence and therefore reduce the chance of infection and 
untimely death. 
Following a high cervical SCI, specifically a C2Hx, there is damage to the 
bulbospinal pathway that transmits an excitatory impulse from the rVRGs in the medulla to 
the PN in the cervical spinal cord (C3-C6, rat) (DeVries and Goshgarian, 1989). After injury 
the PN is unable to effectively stimulate the diaphragm via the phrenic nerves, resulting 
respiratory stress. However, the CPP, remains intact following a C2Hx since the CPP 
decussates caudal to the hemisection (Porter, 1895; Moreno et al., 1992; for review 
Goshgarian, 2003) (Fig. 1).  In the rat model, pharmacological activation of the CPP has 
been shown to restore diaphragm function following systemic administration of theophylline 
(Nantwi et al., 1996; Nantwi et al., 2003a; Kajana and Goshgarian, 2008a).  
Theophylline, acting as a bronchodilator, has an established clinical history as 
discussed in the introduction (page 1). However, when administered to humans systemically 
(oral or intravenous) at therapeutic doses equal to or greater than 20mg/mL (measured as 
plasma levels), there are unwanted side effects such as nausea, vomiting, nervousness, 
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increased or irregular heartbeat, restlessness, and insomnia (Tzelepis et al., 2006; Barnes, 
2013). The side effects following systemic administration in humans are related to an 
elevated plasma concentration of the drug that causes global phosphodiesterase inhibition 
and adenosine A1-receptor antagonism, which affects numerous central nervous system 
centers (Barnes, 2013). Further efforts to investigate the clinical outcome of systemic 
theophylline administration have been abandoned due to intolerable side effects and lack 
of quality data.   
Collectively, the past studies provide key information on the anatomy and function 
of the CPP that can be stimulated to re-establish diaphragm function following SCI. Due to 
the intolerable side effects of theophylline at a therapeutic dose in humans, an alternative 
to systemic administration was needed. Being able to target the drug to select respiratory 
nuclei has potential to greatly reduce the therapeutic dose and to decrease or eliminate 
unwanted side effects.    
The key to delivering a drug to select populations of respiratory nuclei is wheat germ 
agglutinin (WGA). Commonly WGA is bound to horseradish peroxidase (WGA-HRP) as a 
means to visualize WGA following chemical reactions. WGA, a lectin, has an affinity to N-
acetyl-d-glucosamine and sialic acid which are components of glycoconjugates is found on 
most neuronal cell membranes (Borges and Sidman, 1982; Fabian and Coulter, 1985; 
Robertson, 1990). These substances act as receptors when WGA-HRP is injected into 
muscle (Borges and Sidman, 1982; Fabian and Coulter, 1985; Robertson, 1990). 
Subsequently, WGA-HRP undergoes receptor-mediated endocytosis, and is retrogradely 
transported within the axon. In the electron microscopic studies of Schwab et al. (1979), the 
selective release of WGA-HRP from postsynaptic dendrites followed by the rapid uptake of 
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WGA-HRP into presynaptic nerve terminals was observed, thus demonstrating the 
retrograde transsynaptic transport of WGA-HRP.  
Based on the demonstration of transsynaptic transport of WGA-HRP in the phrenic 
motor system following a C2Hx (Moreno et al., 1992), WGA-HRP was utilized to target drug 
delivery to the motoneurons of the PN and the pre-motor rVRG neurons involved in 
diaphragm function. In order to bind theophylline (or drug of choice) to WGA-HRP, a carrier 
was needed to facilitate the chemical conjugation. Gold (Au) nanoparticles (NPs) were 
chosen as a carrier. In vivo application of AuNPs has been established in the literature and 
are known for their biocompatibility, low toxicity, and easy attachment of various structures 
via chemical bonds to the AuNPs (De Jong et al, 2008; Chen et al., 2009; Duncan et al., 
2010; Jain 2010; Thakor et al., 2011; Dreaden et al., 2011; Dreaden et al., 2012; Zhou et 
al., 2013; Cheng et al., 2013; Mieszawska et al., 2013).  
Following a C2Hx, Minic and colleagues (2016) injected into the ipsilateral 
hemidiaphragm a nanoconjugate consisting of WGA-HRP, AuNP and 1,3-dipropyl-8-
cyclopentylxanthine (DPCPX). DPCPX, a specific A1 adenosine receptor antagonist has 
been shown to restore ipsilateral phrenic nerve activity following systemic administration 
(Nantwi et al., 1996; Goshgarian and Nantwi, 2001; Kajana and Goshgarian, 2008). 
Following injection of the DPCPX nanoconjugate, there was a return of activity to the 
ipsilateral phrenic nerve and hemidiaphragm. However, theophylline, not DPCPX, has been 
approved for use in humans to treat respiratory diseases. Therefore, the purpose of the 
following study was to investigate the possibility that a nanoconjugate could be synthesized 
with theophylline in place of DPCPX and used to induced recovery.        
The nanoconjugate used in the following study consists of three parts; a transporter 
(WGA-HRP), a carrier (gold nanoparticle, AuNP), and a drug (proTHP) (Fig. 30). The 
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carrier, AuNP, was used to chemically link the drug to the transporter. To link theophylline 
a hydroxymethyl group was added to theophylline creating 7-(hydroxymethyl)-theophylline 
or “proTHP” (Zhang et al., 2016). ProTHP was then linked to the AuNP via a biodegradable 
ester bond to enable in vivo drug release (Zhang et al., 2016). The experimental 
nanoconjugate and all control nanoconjugates were synthesized by our collaborators in the 
Department of Chemical Engineering and Materials Science at Wayne State University, Dr. 
Guangzhao Mao, Dr. Yanhua Zhang, and Fangchao Liu.   
 
Figure 30: Schematic of the fabrication of the tripartite nanoconjugate.  
HCHO/Et3N; formaldehyde/triethylamine; THF, Tetrahydrofuran; HAuCl4, chloroauric acid; 
NaBH4, Sodium borohydride; Au, gold; MSA, mercaptosuccinic acid; EDC, 1-Ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride; DMAP, 4-Dimethylaminopyridine; WGA-
HRP, wheat germ agglutinin-horseradish peroxidase; NHS, N-Hydroxysuccinimide. Zhang 
et al., 2016. 
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Following injection into the diaphragm, similar to WGA-HRP, the nanoconjugate is 
expected to undergo receptor mediated endocytosis. Once endocytosed, the 
nanoconjugate is expected to be transported in a retrograde manner to the PN in the spinal 
cord followed by retrograde transsynaptic transport to the rVRGs in the medulla. The ester 
bond linking the AuNP to proTHP is transient, resulting in the release of proTHP following 
injection (Zhang et al., 2016). In contrast the peptide (amide) bond between WGA-HRP and 
the AuNP is permanent.  
Visualization of the WGA-HRP-AuNP-proTHP nanoconjugate  
 A total of 5 rats underwent intradiaphragmatic injections to visualize the location(s) 
of the nanoconjugate following injection. An immunohistochemistry technique (see 
Methods) was utilized to visualize the WGA component of the nanoconjugate. The WGA-
HRP-AuNP amide bond is permanent whereas the AuNP-proTHP ester bond is transient. 
Therefore, the location of WGA should also identify where the AuNPs are but not 
necessarily the proTHP. All 5 rats revealed the same results. WGA positive cells were 
identified in the ipsilateral phrenic nuclei in the spinal cord and bilateral in the rVRGs in the 
medulla (Fig. 31). These results suggest that the WGA-HRP portion of the nanoconjugate 
is capable of being transported to the PN and subsequently to the rVRGs following 
intradiaphragmatic injection.  
Nanoconjugate synthesis  
All nanoconjugates used in this study were synthesized according to Zhang et al., 
2016. To determine the drug concentration of each batch, thermogravimetric analysis (TGA) 
was completed on all nanoconjugate batches (Table 5). The variation of proTHP bound to 
each AuNP as demonstrated by TGA, highlights the importance of verifying every batch 
produced, even if identical protocols were used during synthesis. TGA provides information  
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Figure 31: Cervical spinal cord and medulla sections displaying WGA labeling 
following nanoconjugate injection. (A) Transverse section of the cervical spinal cord 
displaying ipsilateral anti-WGA positive labeling in the phrenic nuclei (PN) following 
intradiaphragmatic injection of the WGA-HRP-Au-pro-THP nanoconjugate. There is a lack 
of labeling in the contralateral PN. Scale bar 200um, P notes pinhole to mark side 
contralateral to the injection. (B) Higher magnification of the ipsilateral PN shown in A 
displaying fluorescence from the anti-WGA antibody. (C) Higher magnification of the 
contralateral PN shown in A with a complete lack of WGA label. Scale bar 50um. (D and E) 
Transverse sections of the medulla at the level of the rVRGs from the same rat shown in A. 
(D) Ipsilateral rVRG displaying fluorescence from the anti-WGA antibody. (E) Contralateral 
rVRG displaying fluorescence from the WGA antibody. P notes pinhole to mark side 
contralateral to the injection. Scale bar 200um. (F) Higher magnification of the ipsilateral 
rVRG show in D. (G) Higher magnification of the contralateral rVRG shown in E. Scale bar 
50um. Zhang et al., 2016  
 
 
Synthesis Date 
Average Amount of 
proTHP molecules 
per one AuNP 
Concentration of proTHP 
(mg/ml) in nanoconjugate 
solution containing AuNP = 
4mg/ml 
2/17/2014 532.95 1.1508 
3/14/3014 277.12 0.5984 
4/4/2014 218.030 0.471 
8/15/2014 341.54 0.7376 
1/12/2015 768.15 1.6588 
2/17/2015 330.076 0.713 
3/2/2015 754.41 1.6416 
6/8/2015 202.030 0.436 
7/20/2015 248.212 0.536 
 
Table 5: Thermogravimetric analysis of WGA-HRP-AuNP-proTHP nanoconjugates. 
Each batch underwent Thermogravimetric analysis (TGA) to determine the drug 
concentration of each solution. TGA detects how many proTHP molecules are bound to 
each AuNP. The drug concentration in mg/ml can be calculated using the concentration of 
the AuNP combined with the TGA data. TGA is necessary to ensure each rat is receiving 
the same dose of proTHP when multiple batches are being compared.  
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that can be applied to each nanoconjugate batch to calculate the exact volume needed to 
deliver a set dose. All nanoconjugate solutions had an AuNP concentration of 4mg/ml. For 
example, a nanoconjugate with 202 proTHP molecules per one AuNP results in a proTHP 
concentration of 0.436 mg/ml, whereas a nanoconjugate with 248 proTHP molecules per 
one AuNP has a proTHP concentration of 0.536 mg/ml. This leads to differences in the 
volume required to administer a set proTHP dose. To administer the dose of 0.03mg/kg 
proTHP for a 400-gram rat, 28µl of the solution containing 202 proTHP per AuNP must be 
administered. In contrast to administer the same dose of 0.03mg/kg proTHP for a 400-gram 
rat, 23µl of the solution containing 248 proTHP molecules per AuNP must be administered.   
EMG response to WGA-HRP-AuNP-proTHP and control solutions 
 Five doses of the nanoconjugate based on proTHP concentration (0.03mg/kg, 
0.07mg/kg, 0.12mg/kg, 0.14mg/kg, 0.25mg/kg) were analyzed by EMG (Minic et al., 2016) 
on days 2 through 14 post injection. All proTHP doses were confirmed with TGA analysis. 
EMG functional recovery of the diaphragm after a one-time injection of the nanoconjugate 
proTHP dose of 0.03mg/kg, was detected as early as day 2 post nanoconjugate injection 
and persisted up to 14 days in 65% of the rats (N=20) (Fig. 32). Similarly, the 0.07mg/kg 
proTHP nanoconjugate dose resulted in recovery in 57% of the rats (N=21) (Fig. 33), the 
0.12mg/kg proTHP nanoconjugate dose resulted in recovery in 27% of the rats (N=11) (Fig. 
34), the 0.14mg/kg proTHP nanoconjugate dose resulted in recovery in 44% of the rats 
(N=18) (Fig. 35), and the 0.25mg/kg proTHP nanoconjugate dose resulted in recovery in 
14% of the rats (N=7). Nevertheless, there were some noticeable qualitative differences 
between the experimental groups. Rats that received a 0.03mg/kg dose often had weaker 
bursts compared to those observed in rats in the 0.07mg/kg dose group (Fig. 36). Rats from 
the 0.12mg/kg and 0.14mg/kg dose groups typically had stronger bursts similar to the 
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0.07mg/kg dose group. However, in several rats from the 0.12mg/kg and 0.14mg/kg dose 
groups, the LHD burst frequency was sporadic (non-phasic) and sometimes off rhythm 
compared to the right side, a possible effect of over stimulation (Fig. 35). Interestingly 
several rats from the 0.14mg/kg group presented challenges while trying to stabilize them 
under anesthesia. To reach the anesthetic plane for an EMG procedure, these rats required 
multiple supplemental doses of anesthesia compared to one dose needed in all other 
groups. 
 
 
 
Figure 32: EMG traces day 7 post injection 0.03mg/kg nanoconjugate. Day 7 post 
injection of the 0.03mg/kg dose nanoconjugate. There is a return of the phasic bursting 
pattern from the left hemidiaphragm (top trace). The bursts from the left hemidiaphragm 
match those in the right hemidiaphragm (bottom trace). The sharp spikes in all traces are 
EKG activity. 
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Figure 33: EMG traces day 2 and day 14 post injection of 0.07mg/kg nanoconjugate. 
Both recordings were obtained from the same rat. (A) Day 2 post injection of the 0.07mg/kg 
dose nanoconjugate there is a return of the phasic bursting pattern from the left 
hemidiaphragm (top trace). The bursts from the left hemidiaphragm match those from the 
right hemidiaphragm (bottom trace). (B) Day 14 post injection, the activity has persisted in 
the left hemidiaphragm (top trace) and remains phasic and synchronous with the right 
hemidiaphragm (bottom trace). In both traces an augmented breath is demonstrated 
(arrows) followed by a short period of apnea. This demonstrates that the CPP is intact and 
is functional. The sharp spikes in all traces are EKG activity. 
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Figure 34: EMG traces day 5 post injection 0.12mg/kg nanoconjugate. Day 5 post 
injection of the 0.12mg/kg dose nanoconjugate there is a return of the phasic bursting 
pattern from the left hemidiaphragm (top trace). The bursts from the left hemidiaphragm 
match those from the right hemidiaphragm (bottom trace). In both traces an augmented 
breath is demonstrated (arrows) followed by a short period of apnea. The sharp spikes in 
all traces are EKG activity. 
 
Figure 35: EMG traces day 2 post injection 0.14mg/kg dose. (A) and (B), day 2 post 
injection of the high dose (0.14mg/kg) nanoconjugate there is a small return of the bursting 
pattern (arrows) from the left hemidiaphragm (A and B top traces) but the pattern is sporadic 
(non-phasic) and out of sync with the right hemidiaphragm (A and B bottom traces). B, 
exhibits an augmented breath followed by a short period of apnea. The sharp spikes in all 
traces are EKG activity 
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Figure 36: EMG traces from LHD day 7 post injection; 0.03mg/kg vs 0.07mg/kg. Traces 
from the left hemidiaphragm of a rat that received a 0.07mg/kg dose (top trace) and a rat 
that received a 0.03mg/kg dose (bottom trace). Note in the four areas highlighted that the 
burst from the 0.07mg/kg dose produces a more robust burst than the 0.03mg/kg dose. 
 
 Injection of a control solution containing a conjugate of AuNP-proTHP 0.03mg/kg 
(no WGA-HRP) (N=9), or WGA-HRP-AuNP (no proTHP) (N=8) failed to produced recovery 
of the LHD (Fig. 37). To determine the effectiveness of the nanoconjugate, proTHP (7-
(hydroxymethyl)-theophylline, see methods) in saline (0.07mg/kg) was injected into the 
diaphragm. The proTHP dose of 0.07mg/kg resulted in recovery in 40% of the rats (N= 5) 
(Fig. 38). Two additional rats were injected with the same saline used to dissolve the 
proTHP. Both rats injected with saline lacked functional recovery in all follow up EMG 
recordings (Fig. 39). 
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Figure 37: EMG traces post injection of control solutions. (A) Following injection of the 
WGA-HRP-AuNP control the left hemidiaphragm remains inactive (top trace) with the 
exception of the CPP demonstrated by the augmented breath (arrows). The right 
hemidiaphragm maintains phasic bursting activity (bottom trace). (B) Following injection of 
the 0.03mg/kg AuNP-proTHP control the left hemidiaphragm remains inactive (top trace) 
while the right hemidiaphragm maintains phasic bursting activity (bottom trace). 
 
Figure 38: EMG traces day 5 post injection of proTHP 0.07mg/kg in diaphragm. 
Following injection of proTHP there is a return of the bursting pattern from the left 
hemidiaphragm (top trace) that matches the phasic bursts of the right hemidiaphragm 
(bottom trace). 
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Figure 39: EMG traces from the left and right hemidiaphragm day 7 post injection of 
saline. Day 7 post injection of the saline control the left hemidiaphragm remains inactive 
(top trace). The right hemidiaphragm maintains phasic bursting activity (bottom trace). 
 
 
Statistical significance of functional recovery occurrence, detected with EMG 
analysis, was determined using the Chi Square-Fisher’s exact test followed by the 
Bonferroni adjustment (Fig 40, Minic et al., 2016). Treatment with 0.03mg/kg of the pro THP 
nanoconjugate resulted in significantly greater proportion of rats achieving functional 
recovery when compared to the 0.25mg/kg dose (p=0.033). In addition, treatment with 
0.03mg/kg, 0.07mg/kg, or 0.14mg/kg of the proTHP nanoconjugate resulted in a 
significantly greater proportion of rats achieving functional recovery when compared to the 
control 0.03mg/kg AuNP-proTHP; (p=0.002), (p=0.009), (p=0.031) respectively. Treatment 
with 0.03mg/kg, 0.07mg/kg, or 0.14mg/kg also resulted in a significantly greater proportion 
of rats achieving functional recovery when compared to the control WGA-HRP-AuNP; 
(p=0.001), (p=0.004), (p=0.026) respectively.  
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Figure 40: Percent Recovery Detected by EMG. The chart displays the percentage of 
rats in each group that had left hemidiaphragm recovery detected by EMG. Statistical 
analysis consisted of data from 120 rats. A Chi-square test was performed and significance 
was found between the proportions of observations (Yes/No) and the groups, X2 (9, N = 
120) = 23.749, p = 0.005. The Fisher exact test found significance between the following 
pairwise comparisons; 0.03mg/kg vs. 0.25mg/kg (p=0.033, #); 0.03mg/kg vs. WGA-HRP-
AuNP (p=0.001, #); 0.03mg/kg vs. 0.03 AuNP-proTHP (p=0.002, #); 0.07mg/kg vs. 0.03 
AuNP-proTHP (p=0.009, +); 0.07mg/kg vs. WGA-HRP-AuNP (p=0.004, +); 0.14mg/kg vs. 
0.03AuNP-proTHP (p=0.031, *); 0.14mg/kg vs. WGA-HRP-AuNP (p=0.026, *).  
 
 
79 
 
Based on EMG data, the previously paralyzed hemidiaphragm can be stimulated 
following injection of the nanoconjugate. The return of hemidiaphragm function can be 
detected as early as day 2 post injection, and persists for the duration of the experiment, 
up to and including day 14 post injection. All five nanoconjugate doses produced recovery 
as detected by EMG.  
Injection of control solutions containing saline, WGA-HRP-AuNP, or AuNP-proTHP 
were unable to stimulate any detectable hemidiaphragm activity. Interestingly, the 
remaining control solution proTHP dissolved in saline, injected intradiaphragmatically, did 
result in activity detectable by EMG. However, with data only from the EMG, it is unclear as 
to whether this is isolated muscle activity stimulated by the injection or proTHP (Bianchi 
1961; Isaacson and Sandow, 1967; Kentera and Varagic, 1975; Jones et al., 1982; Creed 
et al., 1983; Supinski et al., 1984), or if it is a return of function mediated by the bulbospinal 
pathway via the phrenic nerve.  
Phrenic nerve response to WGA-HRP-AuNP-proTHP and control solutions 
Bilateral phrenic nerve recordings were used to quantify recovery on days 3, 7, and 
14 following nanoconjugate injection of the three doses with the highest occurrence of 
diaphragm recovery as characterized by EMG. See Methods for details.  
One-way ANOVA showed significant drug effect on day 3 between the 0.14mg/kg 
dose and the remaining two groups, 0.03mg/kg dose and 0.07mg/kg dose for the INT 
(p<0.001) and the MAX (p<0.001) (Fig. 41, Table 6). This data suggests that at the day 3-
time point, the 0.14mg/kg dose nanoconjugate is the most effective at restoring LPN activity 
with 5.1±0.8% INT and 8.2±1.4% MAX LPN recovery. 
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Figure 41: Comparison of Day 3 Nerve Recordings. The average percent integrated (top 
graph) and average percent maximum amplitude (bottom graph). Statistical data consisted 
of neurograms from 21 rats (Table 6). One-way ANOVA showed significant drug effect on 
day 3 between the 0.14mg/kg dose and the remaining two groups, 0.03mg/kg dose and 
0.07mg/kg dose for the integrated waveform (p<0.001) and the maximal amplitudes 
(p<0.001). 
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Nanoconjugate Dose 
Administered 
Percent INT Percent MAX 
0.03mg/kg 0.4±0.2%  1.8±1.2% 
0.07mg/kg 0.002±0.005%  0.2±0.7% 
0.14mg/kg 5.1±0.8%  8.2±1.4% 
 
Table 6: Left phrenic nerve percent recovery on day 3. The percent integrated (INT) and 
percent maximum amplitude (MAX) of the left phrenic nerve compared to the right phrenic 
nerve. Statistical data consisted of neurograms from 21 rats. One-way ANOVA showed 
significant drug effect on day 3 between the 0.14mg/kg dose and the remaining two groups, 
0.03mg/kg dose and 0.07mg/kg dose for the integrated waveform (p<0.001) and the 
maximal amplitudes (p<0.001). 
 
One-way ANOVA showed no significant drug effect on day 7 for either the INT or 
the MAX (Fig. 42, Table 7). The dose 0.14mg/kg demonstrated the highest percent recovery 
following nanoconjugate administration with 0.6±1.3% INT and 3.8±8.4% MAX LPN 
recovery. The control solution 0.07mg/kg proTHP dissolved in saline, injected 
intradiaphragmatically demonstrated 0.5±0.1% INT and 1.5±0.4% MAX LPN recovery. The 
LPN signal was detected in the remaining two controls WGA-HRP-AuNP and AuNP-
proTHP, however the amount was negligible; 0.01±0.02% INT, 0.6±1.0% MAX and 
0.004±0.01% INT, 0.3±1.0% MAX respectively.  
One-way ANOVA showed significant drug effect on day 14 for the INT between the 
0.03mg/kg dose and the 0.07mg/kg dose (p=0.042). The was also significant drug effect for 
the MAX between the 0.03mg/kg dose and the remaining two doses 0.07mg/kg (p<0.001) 
and 0.14mg/kg (p<0.001) (Fig. 43, Table 8). This data suggests that at the day 14-time 
point, the 0.03mg/kg dose nanoconjugate is the most effective at restoring LPN activity with 
2.3±0.9% INT and 7.9±2.2% MAX LPN recovery  
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Figure 42: Comparison of Day 7 Nerve Recordings. The average percent integrated (top 
graph) and average percent maximum amplitude (bottom graph). Statistical data consisted 
of neurograms from 30 rats (Table 7). One-way ANOVA showed no significant drug effect 
on day 7 for the integrated waveform or the maximal amplitudes. 
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Figure 43: Comparison of Day 14 Nerve Recordings. The average percent integrated 
(top graph) and average percent maximum amplitude (bottom graph). Statistical data 
consisted of neurograms from 17 rats (Table 8). One-way ANOVA showed significant drug 
effect on day 14 for the integrated waveform between the 0.03mg/kg dose and the 
0.07mg/kg dose (p=0.042). The was also significant drug effect for the maximal amplitudes 
between the 0.03mg/kg dose and the remaining two doses 0.07mg/kg (p<0.001) and 
0.14mg/kg (p<0.001).  
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Administered Solution Percent INT Percent MAX 
0.03mg/kg nanoconjugate 0.01±0.04%  0.3±0.9% 
0.07mg/kg nanoconjugate 0.4±0.3%  2.3±1.9% 
0.14mg/kg nanoconjugate 0.6±1.3%  3.8±8.4% 
WGA-HRP-AuNP 0.01±0.02%  0.6±1.0% 
0.03mg/kg AuNP-proTHP 0.004±0.01%  0.3±1.0% 
0.07mg/kg proTHP 0.5±0.1%  1.5±0.4% 
 
Table 7: Left phrenic nerve percent recovery on day 7. The percent integrated (INT) and 
percent maximum amplitude (MAX) of the left phrenic nerve compared to the right phrenic 
nerve. Statistical data consisted of neurograms from 30 rats. One-way ANOVA showed no 
significant drug effect on day 7 for the integrated waveform or the maximal amplitudes. 
 
 
Nanoconjugate Dose 
Administered 
Percent INT Percent MAX 
0.03mg/kg 2.3±0.9%  7.9±2.2% 
0.07mg/kg 0.7±0.2%  2.3±0.9% 
0.14mg/kg 0.6±1.7%  1.9±2.4% 
 
Table 8: Left phrenic nerve percent recovery on day 14. The percent integrated (INT) 
and percent maximum amplitude (MAX) of the left phrenic nerve compared to the right 
phrenic nerve. Statistical data consisted of neurograms from 17 rats. One-way ANOVA 
showed significant drug effect on day 14 for the integrated waveform between the 
0.03mg/kg dose and the 0.07mg/kg dose (p=0.042). The was also significant drug effect for 
the maximal amplitudes between the 0.03mg/kg dose and the remaining two doses 
0.07mg/kg (p<0.001) and 0.14mg/kg (p<0.001).  
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Based on statistical analysis of the neurograms, both the 0.14mg/kg and 0.03mg/kg 
doses had a significant drug effect for different time points; day 3, day 14 respectively. This 
variance may demonstrate the effect of proTHP over time. 
To determine the effect of proTHP over time, the neurograms sampled for each dose 
at the three time points, day 3, 7, and 14, were compared. The 0.03mg/kg dose group had 
a total of 20 rats. One-way ANOVA showed a significant drug effect on day 14 for both the 
integrated waveform and the maximal amplitudes p<0.001 (Fig. 44). This data suggests the 
dose 0.03mg/kg does not have an immediate effect but is more effective over time.  
 
Figure 44: Dose 0.03mg/kg Nerve Recordings. The average percent integrated (top 
graph) and average percent maximum amplitude (bottom graph). Statistical data consisted 
of neurograms from 20 rats. One-way ANOVA showed significant drug effect on day 14 for 
both the integrated waveform or the maximal amplitudes p<0.001. 
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The 0.07mg/kg dose group consisted of 14 rats. One-way ANOVA showed 
significant drug effect for the integrated waveform on day 14 for both the integrated 
waveform [day 3 vs. day 7 (p=0.003); day 3 vs. day 14 (p<0.001); day 7 vs. day 14 
(p=0.014)], and the maximal amplitudes [day 3 vs. day 7 (p=0.048); day 3 vs. day 14 
(p=0.003)] (Fig. 45). This data suggests the dose 0.07mg/kg, similar to 0.03mg/kg, is more 
effective over time.  
 
Figure 45: Dose 0.07mg/kg Nerve Recordings. The average percent integrated (top 
graph) and average percent maximum amplitude (bottom graph). Statistical data consisted 
of neurograms from 17 rats. One-way ANOVA showed significant drug effect for the 
integrated waveform between all days sampled, day 3 vs. day 7 (p=0.003); day 3 vs. day 
14 (p<0.001); day 7 vs. day 14 (p=0.014). The maximal amplitudes showed significance for 
day 3 only; vs. day 7 (p=0.048); vs. day 14 (p=0.003). 
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The 0.14mg/kg dose group consisted of 17 rats. One-way ANOVA showed 
significant drug effect for the integrated waveform on day 3 for the integrated waveform 
(p<0.001), but showed no significance for the maximal amplitudes (Fig. 46). This suggests 
that the 0.14mg/kg dose has an immediate effect that wears off over time. Alternatively, the 
decrease could be a result of overstimulation appearing as a decrease in LPN activity at 
the later time points (Nantwi et al, 1996).  
  
Figure 46: Dose 0.14mg/kg Nerve Recordings. The average percent integrated (top 
graph) and average percent maximum amplitude (bottom graph). Statistical data consisted 
of neurograms from 17 rats. One-way ANOVA showed significant drug effect for the 
integrated waveform on day 3 for the integrated waveform (p<0.001), but showed no 
significance for the maximal amplitudes. 
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Discussion  
Visualization 
WGA-HRP was chosen as the transporter to mediate the selective uptake of the 
nanoconjugate. This was accomplished by using the unique relationship between WGA and 
receptors on the phrenic motoneuron axon terminals at the neuromuscular junction. The 
role of HRP was to provide a method to visualize the WGA-HRP-AuNP component following 
injection. Unfortunately, the chemical reactions to visualize HRP were inconsistent. There 
was concern that the amount of HRP in the system was so miniscule, thus creating the 
challenge to consistently detect HRP. In an effort to amplify the signal, a technique to bind 
antibodies to the WGA component was implemented. The technique to visualize WGA 
proved to be stable and reproducible as demonstrated by the study investigating the 
DPCPX nanoconjugate (Minic et al., 2016). The establishment of a protocol to detect WGA 
suggests that HRP is dispensable, i.e. it is not important for the uptake of WGA at the 
phrenic neuromuscular terminals. 
In this study, WGA was detected in the ipsilateral phrenic nuclei and bilaterally in 
the rVRGs on day 3 post nanoconjugate injection. Due to the permanent amide bond 
between WGA-HRP and AuNP, it is thought that the AuNPs are also located in the ipsilateral 
phrenic nuclei and bilateral rVRGs. In an effort to determine the AuNPs location(s) post 
injection, a biodistribution study is currently underway.  
At this time, we are unable to visualize the proTHP portion of the nanoconjugate in 
vivo. The ester bond was designed to release proTHP intracellularly, ideally within the 
phrenic motoneurons and rVRG pre-motor neurons. The presence of proTHP would 
stimulate these neurons, resulting in recovery of the diaphragm. It has been confirmed in a 
solution of artificial cerebral spinal fluid, at a 12-hour time point, that the ester bonds are 
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broken and proTHP has been released. Further studies to detail the release of proTHP, and 
DPCPX, including release in a solution more similar to the intracellular environment and pH 
are underway. In addition, a study to identify where in the cell the ester bond is broken is 
being developed.  
Interestingly in comparison to the WGA-HRP-AuNP-proTHP nanoconjugate, the 
WGA-HRP-AuNP-DPCPX nanoconjugate was also detected bilaterally in the rVRGs but 
was bilaterally detected in the PN (Minic et al., 2016). This is an interesting finding since 
both experiments followed the same protocol. At day 7 post injection, the highest average 
integrated waveform from the proTHP nanoconjugate was 0.55±1.3%, whereas the DPCPX 
nanoconjugate produced a staggering 56.8±4.3% recovery. Moreover, on day 14 the 
proTHP nanoconjugate produced 2.26±0.9% LPN recovery compared to the DPCPX 
nanoconjugate with 72.4±7.3% LPN recovery. In the DPCPX study, the presence of WGA 
in both phrenic nuclei, suggests the DPCPX nanoconjugate has greater mobility. This could 
play a part in the notable effectiveness of the DPCPX nanoconjugate compared to the 
proTHP nanoconjugate.   
EMG analysis 
The results from EMG analysis demonstrate that all five nanoconjugate doses were 
able to stimulate recovery of LHD activity detected as early as day 2 post injection and 
persisted up to 14 days. EMG results suggest the dose 0.03mg/kg to be most effective as 
it produced a 65% recovery rate, higher than all remaining doses. Significance of the 
recovery percent rate was detected in between the nanoconjugate groups, and two of the 
controls WGA-HRP-AuNP and 0.03mg/kg AuNP-proTHP. As reported in the results, 
sporadic (non-phasic) bursts were detected in the 0.12mg/kg and 0.14mg/kg groups, a 
possible effect of over stimulation (Nantwi et al., 1996). In addition, several of the 0.14mg/kg 
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dose rats presented difficulty when putting them under anesthesia for follow up procedures, 
often requiring supplemental anesthesia injections before beginning the procedure. Both of 
these observations suggest that 0.14mg/kg is over stimulating, or hyper-activating, the 
respiratory system. Following injection of the highest nanoconjugate dose of 0.25mg/kg, 
recovery was detected in 1 rat out of 7 (14%). The dose 0.25mg/kg resulted in the lowest 
percent recovery, suggesting a suppression of respiratory system activity when a higher 
dose of theophylline is administered (Nantwi et al., 1996).     
The control solutions, WGA-HRP-AuNP and 0.03mg/kg AuNP-proTHP did not 
produce LHD recovery in any of the rats tested. It is interesting to note that AuNP-proTHP 
was unable to produce LHD recovery even though proTHP was present. The explanation 
behind this remains elusive; one possibility is that without the WGA-HRP, AuNP-proTHP 
remains within the muscle (extracellularly) until the conjugate is cleared. Remaining in the 
diaphragm could prevent the degradation of the ester bond which is designed to dissociate 
proTHP from AuNP in a pH similar to that found intracellularly, which is more acidic than 
the extracellular environment (Adler et al., 1965; Deutsch et al., 1982). 
Interestingly the intradiaphragmatic injection of proTHP dissolved in saline was able 
to produce diaphragm activity in 40% of the rats, whereas saline alone was not. However, 
upon further investigation, injecting theophylline into the muscle may provoke a systemic 
response manifesting in muscle contractions (Bianchi 1961; Isaacson and Sandow, 1967; 
Kentera and Varagic, 1975; Jones et al., 1982; Creed et al., 1983; Supinski et al., 1984). It 
is important to point out that drug induced contractions within the diaphragm does not 
equate phrenic nerve activity. Being able to provoke contractions of the diaphragm following 
intradiaphragmatic injection of proTHP or the tripartite nanoconjugate highlights the 
importance of characterizing recovery with EMG and phrenic nerve recordings.  
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Bilateral Phrenic Nerve Recordings  
To better understand the effect of the nanoconjugate, quantification of bilateral nerve 
recordings under standardize conditions were compared between groups. Phrenic nerve 
recordings detected bilateral phrenic nerve activity in all groups. Beginning with the nerve 
recordings sampled on day 3, the 0.14mg/kg dose group produced a significantly greater 
percent recovery for the average percent integrated waveform, and the maximum 
amplitude. However, the average percent for the 0.14mg/kg integrated waveform was only 
5.12±0.8% LPN activity compared to the RPN. On day 7, there was no significance 
detected between experimental and control groups. The 0.14mg/kg group was again the 
group with the highest integrated waveform, but the day 7 average integrated waveform 
decreased to 0.55±1.3% LPN activity compared to the RPN.  
Interestingly on day 14 the 0.03mg/kg dose demonstrated significantly greater 
percent recovery than the 0.07mg/kg and 0.14mg/kg groups with an integrated waveform 
of 2.26±0.9% LPN activity. The variations of percent recovery for the 3 nanoconjugate 
doses over the course of the study might demonstrate the effect on respiration as proTHP 
is metabolized over time. The 0.03mg/kg dose is 0.4±0.2% on days 3 and 7, then jumps up 
to 2.3±0.9% on day 14. Similarly, the LPN percent recovery following a 0.07mg/kg dose is 
barely detectable on day 3, followed by a significant increase in percent recovery that 
continues to increase up to day 14. Conversely the 0.14mg/kg dose started out strong with 
5.1±0.8% LPN recovery followed by a significant decline in activity for the remainder of the 
study. This pattern following the 0.14mg/kg dose, could depict a strong response from the 
initial proTHP exposure followed by an inhibitory effect in the subsequent days. The 
inhibition of phrenic nerve activity following a high dose of theophylline has been described 
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before (Nantwi et al., 1996; Nantwi et al., 2003b). However, this is the first time theophylline 
appears to stimulate phrenic nerve activity followed by an inhibition of activity.  
Considering the results for both the EMG and phrenic nerve recordings following 
injection of the tripartite nanoconjugate and control solutions; it is possible that recovery 
following nanoconjugate injection is the result of a systemic effect following 
intradiaphragmatic injection, an effect of the release of proTHP in the PN and rVRGs 
following WGA mediated endocytosis, or a combination of both. The rationale behind a 
systemic effect is based on the observations following injection of the control proTHP in 
saline that demonstrated a 40% occurrence of LHD recovery detected by EMG, and 
0.5±0.1% LPN activity compared to the RPN on day 7. The results produced by injection 
proTHP alone compared to the nanoconjugate at the same 0.07mg/kg dose, 57% 
occurrence of LHD and 0.4±0.3% LPN activity on day 7, suggests the recovery observed 
following nanoconjugate injection is primarily systemic. Visualization of WGA in the 
ipsilateral phrenic nuclei and bilaterally in the rVRGs confirms that the WGA component is 
able to mediate intracellular transport following injection, but the presence of proTHP in 
these locations are not confirmable at this time.  
Regardless of where or how proTHP is acting, a maximum integrated waveform of 
5.12±0.8% LPN activity following nanoconjugate injection is poor recovery. Fortunately, in 
addition to theophylline there are multiple drugs known to enhance respiration following high 
SCI including DPCPX, a specific A1 adenosine receptor antagonist (Nantwi et al., 1996; 
Goshgarian and Nantwi, 2001; Kajana and Goshgarian, 2008). As mentioned in the 
previous section, simultaneous to this study, AuNPs conjugated to WGA-HRP and DPCPX 
were being investigated. Injection of the DPCPX nanoconjugate produces an average 
percent recovery of 56.8% on day 7 and 72.4% on day 14 for the integrated waveforms of 
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the LPN compared to the RPN (Minic et al., 2016). Further investigation into the use of the 
DPCPX nanoconjugate is underway as results are more promising than those detailed in 
this study using proTHP. 
Lastly, concerns about the high AuNP concentration of the proTHP nanoconjugate, 
and possible AuNP aggregation preventing endocytosis, has led to an experiment to 
investigate the rate of recovery following injection of greatly diluted proTHP nanoconjugate 
solution. If there is an aggregation of AuNPs, preventing the uptake of the nanoconjugate, 
reducing the concentration would reduce the chance of aggregation. This could increase 
the WGA mediated uptake, increasing the amount of proTHP exposed to the PN and 
rVRGs, in turn increasing the percent recovery of the LNP.  
Notes on the synthesis of the theophylline nanoconjugate 
Throughout this experiment the complexity of theophylline nanoconjugate synthesis 
became apparent. In order to bind theophylline to the AuNPs a hydroxymethyl group was 
added to the theophylline creating proTHP.  A short length of time between proTHP 
synthesis and nanoconjugate synthesis was critical to make a functional nanoconjugate. 
The final product, proTHP, was originally stored in small vials containing room air. Over time 
the moisture in the air was able to dissociate the hydroxymethyl group, turning an unknown 
amount of proTHP back to THP. This dissociation made the chemical reaction to bind 
proTHP to the AuNPs less effective, resulting in various amounts of proTHP per AuNP. For 
example, when comparing 2 nanoconjugate batches with thermogravimetric analysis (TGA) 
a 5.697% weight variance was detected, which is the difference of 105 molecules of proTHP 
per AuNP and a change in proTHP concentration by 0.22mg/ml. The instability of the 
hydroxymethyl group made apparent the need to characterize every batch with TGA to 
verify uniformity and the actual drug concentration. Confirming the drug concentration with 
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TGA allows the appropriate adjustment in volume to ensure the reported dose is injected. 
The integrity of post-synthesis (ester) bond stability has been emphasized by others 
(Duncan and Gaspar, 2011), therefore It was decided to limit the use of the nanoconjugate 
for no longer than one-month post synthesis. To further protect proTHP, a technique of 
storing newly synthesized proTHP under a layer of argon gas to block moisture, was 
implemented. Further investigation into the effects of the proTHP bound nanoconjugate 
must employ all known methods to stabilize proTHP and must use methods such as TGA 
to verify the actual nanoconjugate drug load. A consideration for future studies is the use of 
a hydroxyethyl theophylline, commercially available from Sigma-Aldrich, in place of the 
hydroxymethyl theophylline synthesized by our collaborators and used in this study. The 
hydroxyethyl theophylline appears to be more stable than the hydroxymethyl theophylline 
and could reduce drug load variance complications. Studies are currently underway to 
determine differences between synthesis and the stability of nanoconjugates synthesized 
with hydroxyethyl theophylline compared to hydroxymethyl theophylline.  
Interestingly the synthesis of the WGA-HRP-AuNP-DPCPX nanoconjugate used in 
the Minic et al., 2016 study did not encounter the same issues stated above. In comparison 
to theophylline, DPCPX has an extra 5 carbon ring causing DPCPX to be more hydrophobic, 
a characteristic that may contribute to the stability of DPCPX during nanoconjugate 
synthesis.  
Closing Statement 
WGA-HRP-AuNP-proTHP nanoconjugates are capable of increasing the amount of 
LPN recovery when injected intradiaphragmatically immediately after C2Hx. Targeting drug 
delivery, reduces the therapeutic dose from 15mg/kg IV (Nantwi et al., 1996) to less than 
0.2mg/kg. In doing so the restored left hemidiaphragm and left phrenic nerve function can 
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be detected as early as day 2 and persists up to day 14 post injection. However, the WGA-
HRP-AuNP-proTHP nanoconjugate used in this study fails to induce the amount of recovery 
following the administration of the WGA-HRP-AuNP-DPCPX nanoconjugate (Minic et al., 
2016).  
Lastly, the application of the WGA-HRP-AuNP nanoconjugate is not limited to the 
phrenic motor system. WGA-HRP has been utilized for decades to identify neuromuscular 
pathways. In theory, injection of the WGA-HRP-AuNP nanoconjugate bound to a variety of 
substances could hold promise for applications in multiple disease and injury models.  
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CHAPTER 3: APPLICATION OF THE THEOPHYLLINE BOUND NANOCONJUGATE IN 
THE CHRONICALLY INJURED SPINAL CORD MODEL 
Summary 
    The chronically C2Hx rat exhibits injury induced plasticity of physiologically active 
synapses in the spinal cord and medullary respiratory centers. Over time, synaptic plasticity 
results in multiple connections to numerous nuclei in addition to those identified in the acute 
C2Hx model as demonstrated by WGA-Alexa 488 labeling (Buttry and Goshgarian, 2014). 
Due to the retrograde transsynaptic transport of WGA, following intradiaphragmatic 
injection, the nanoconjugate is expected to deliver the drug to the additional nuclei identified 
in the chronically C2Hx model. Following nanoconjugate injection, a variable effect in the 
descending respiratory drive was observed. However, the full effect of the proTHP bound 
nanoconjugate in the chronically C2Hx model remains uncertain due to the complex 
environment post injury and variability between individuals. 
Introduction 
Of the estimated 276,000 people living in the United States only 4.5% (12,500 
people) are people with new injuries, meaning the vast majority have a chronic injury 
(NSCISC, 2015). In order for a drug therapy to be considered clinically, administration in 
chronically injured individuals must be considered as well as in the acutely injured. In this 
study chronically injured rats were defined as 12 weeks post C2Hx. This time frame 
provided an adequate recovery period for the central nervous system in the rat C2Hx injury 
model to adapt to the SCI (Nantwi et al., 1999; Golder et al., 2001b; Nantwi et al., 2003a; 
Fuller et al., 2008; Buttry and Goshgarian, 2014). It is well known that in the chronically 
C2Hx injury model the respiratory pathway, as well as accessory pathways discussed in 
Chapter 1, are in a hyperactive state (Goshgarian,1979). This is critical information since 
the therapeutic dose (15 mg/kg theophylline, systemically administered) that stimulates 
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phrenic nerve activity in the acutely C2Hx rat has been shown to inhibit phrenic motor output 
when administered to the chronically C2Hx rat (Nantwi et al., 2003a). Moreover, reducing 
the dose in the chronically C2Hx rats to 5 mg/kg or 2.5 mg/kg also inhibit phrenic nerve 
output or have no effect (Nantwi et al., 2003a).  
To characterize functional recovery in the chronically C2Hx rats flowing 
nanoconjugate injection, EMG analysis and phrenic nerve recordings were used as 
described in Chapter 2 (see methods for additional details). In previous studies 
spontaneous functional recovery of the diaphragm has been documented following C2Hx 
(Nantwi et al., 1999; Golder et al., 2001; Nantwi et al., 2003a; Fuller et al., 2008). However, 
based on the method of measurement, the time frame in which the spontaneous recovery 
occurs varies. In the Chapter 1 chronic studies, EMG recordings immediately prior to 
intradiaphragmatic tracer injections indicated spontaneous functional recovery of the 
diaphragm in 62% of the rats at the time point of 7 weeks post C2Hx or more. Also 
demonstrated in the Chapter 1 studies, in chronically injured rats, there is a change in the 
physiologically active synapses temporally associated with the activation of the diaphragm 
following a C2Hx based on the change in pattern of WGA-Alexa 488 labeling following 
intradiaphragmatic injection. In this study the nanoconjugate was applied to the chronic 
C2Hx injury model with the expectation of WGA mediated transport of the nanoconjugate 
to the nuclei observed in the Chapter 1 chronic C2Hx injury model. Plasticity of 
physiologically active synapses in the chronically C2Hx system has the potential to change 
the distribution of the nanoconjugate due to the properties of WGA receptor mediated 
transsynaptic transport. The change in proTHP distribution could induce recovery following 
12 weeks post C2Hx or strengthen the spontaneously developed recovery. In contrast, the 
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nanoconjugate could have an inhibitory effect similar to systemic administration, blockading 
the descending drive in chronic C2Hx rats as demonstrated by Nantwi et al., 2003a.   
Physiological response to WGA-HRP-AuNP-proTHP 
The chronic study was comprised of data from 27 C2Hx rats. After a 12-week 
recovery period all rats underwent a second EMG to test for spontaneous recovery prior to 
the injection of nanoconjugate. See methods for details.   
Each rat underwent an EMG 3 to 6 days following nanoconjugate injection. Based 
on the EMG results, each rat was placed into a “Recovery/Improvement” or “No 
change/Loss” category. Recovery was defined as a return of diaphragm activity when prior 
to nanoconjugate injection there was a complete absence of diaphragm activity, i.e. no 
spontaneous recovery. An improvement upon spontaneous recovery was defined as activity 
appearing in 1 or more of the 3 diaphragm areas in addition to spontaneous activity. No 
change was defined as no observable activity regained in 1 or more of the 3 areas following 
injection. Lastly, a loss was defined as a loss of spontaneous activity in 1 or more of the 3 
areas of the diaphragm following nanoconjugate injection. Five of the 12 rats (41.67%) 
resulted in improvement following injection of the nanoconjugate at the dose 0.07mg/kg. In 
an effort to increase the amount of rats that exhibited improvement following nanoconjugate 
administration, the dose was lowered to 0.06mg/kg. However, 0.06mg/kg resulted in 
improvement in 1 of 5 rats (20%). The last group to be tested received a dose of 0.02mg/kg, 
and resulted in improvement in 3 of 16 (18.75%). Similar to the EMG analysis in Chapter 2, 
the occurrence of “Recovery/Improvement” or “No change/Loss” were compared to 
determine the dose that produced the most recovery or improved upon existing 
spontaneous recover, however no significance was detected (Fig. 47). 
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Figure 47: Chronic C2Hx model EMG response to nanoconjugate dose. At 12 weeks 
post C2Hx three groups were created based on the nanoconjugate dose injected: 
0.02mg/kg (N=16), 0.06mg/kg (N=5), and 0.07mg/kg (N=4). Each rat underwent a second 
EMG in the days following injection. In the above graph groups are sub-divided into a 
“Recovery/Improvement” or “No change/Loss” category based on return of function or an 
improvement of spontaneous activity or no change or a loss of spontaneous activity. The 
percent of recovery/improvement for the three nanoconjugate doses were compared, no 
significance was found suggesting that proTHP has no effect on chronic animals.  
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 Bilateral phrenic nerve recordings were sampled at 13 weeks (day 7 post 
nanoconjugate injection). Groups were compared to determine the dose that produced the 
most recovery or improvement upon existing spontaneous recovery; 0.02mg/kg (N=10), 
0.06mg/kg (N=3), and 0.07mg/kg (N=3). One-way ANOVA with Holm-Sidak pairwise 
comparison showed a significant dose effect between the groups (p=<0.001). Pairwise 
comparison showed significance between the 0.06mg/kg dose and the remaining two 
doses, 0.02mg/kg and 0.07mg/kg for both the integrated waveform (p<0.001) and maximal 
amplitudes (p<0.001) (Fig. 48). This suggests that on day 7 post nanoconjugate injection 
the 0.06mg/kg dose produces a higher percentage of left phrenic nerve activity than the 
remaining two doses.   
Influence of spontaneous activity on recovery  
 At 12 weeks post C2Hx, 22 of the 27 rats had spontaneous activity, prior to 
nanoconjugate injection, detected by EMG. The WGA component of the nanoconjugate is 
activity dependent and requires muscle activity of the diaphragm to undergo receptor 
mediated endocytosis. Rats that had spontaneous activity prior to injection at 12 weeks post 
C2Hx could have an advantage over rats with no spontaneous activity. Interestingly analysis 
of the occurrence of “Recovery/Improvement” vs. “No change/Loss” based on EMG 
recordings showed no significance for all 3 doses; 0.02mg/kg, 0.06mg/kg, and 0.07mg/kg. 
However, the data from the phrenic nerve recordings revealed that the 0.2mg/kg dose group 
showed significance with the One-way ANOVA with Holm-Sidak pairwise comparison 
(p=<0.001) for the integrated waveform (p<0.001), but not for the maximal amplitudes 
(p=0.003) (Fig. 49). 
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Figure 48: Nerve recording dose comparison in chronically C2Hx. Comparison of the 
average percent integrated (top graph) and average percent maximum amplitude (bottom 
graph) for the chronic groups. Statistical data consisted of neurograms from 17 rats. One-
way ANOVA with Holm-Sidak pairwise comparison showed significant dose effect between 
the groups (p=<0.001). Pairwise comparison showed significance between the 0.06mg/kg 
dose and the remaining two doses, 0.02mg/kg and 0.07mg/kg for both the integrated 
waveform (p<0.001) and maximal amplitudes (p<0.001).  
102 
 
 
Figure 49: Effect of spontaneous recovery on nerve recordings in nanoconjugate 
injected chronically C2Hx rats. Comparison of the average percent integrated (top graph) 
and average percent maximum amplitude (bottom graph) for the chronic group that received 
the 0.02mg/kg dose. Statistical data consisted of neurograms from 8 rats. One Way ANOVA 
with Holm-Sidak pairwise comparison showed significant effect between rats with 
spontaneous recovery vs. those with no spontaneous recovery (p=<0.001). Pairwise 
comparison showed significance between groups for the integrated waveform (p<0.001), 
but not for the maximal amplitudes (p=0.003). 
103 
 
Discussion 
 Application of any drug intended to increase respiratory drive following SCI must be 
characterized in both the acute and chronically injured systems. There are numerous 
differences in the spinal cord and medulla following injury including changes in cell to cell 
connections (Lane et al., 2009; Buttry and Goshgarian, 2014) and how respiration reacts to 
drug intervention (Nantwi et al., 2003a). Plasticity of physiologically active synapses in the 
chronically C2Hx system, as discussed in Chapter 1, has the potential to change the 
distribution of the nanoconjugate due to the properties of WGA receptor mediated 
transsynaptic transport (Buttry and Goshgarian, 2014). Qualitative analysis of the 
occurrence of recovery or improvement upon spontaneous recovery following 
nanoconjugate injection produced no significance between the doses injected. However 
quantitative analysis of phrenic nerve recordings reported a significant increase in the 
amount of left phrenic nerve (LPN) activity following injection of the 0.06mg/kg dose 
compared to 0.02mg/kg and 0.07mg/kg. In addition, chronic rats that had spontaneous 
activity as determined by EMG analysis at 12 weeks post-op followed by injection of 
0.02mg/kg had a significant increase in the amount of LPN activity compared to rats without 
spontaneous activity at 12 weeks post-op followed by injection of 0.02mg/kg 
nanoconjugate. This suggests that the amount of activity present prior to injection may 
influence the effectiveness of the activity dependent WGA mediated endocytosis. Increased 
WGA mediated endocytosis of the nanoconjugate would increase the targeted release of 
proTHP, resulting in a higher delivered drug concentration.  
The chronic results suggest that the targeted drug delivery nanoconjugate based 
approach can be applied to the chronic system to stimulate LPN activity. The chronic study 
consisted of 27 rats and just scratched the surface of the work required to fully characterize 
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the nanoconjugate in the chronically injured system. Further investigation of the doses 
reported in this study as well as control solutions are needed to move forward with chronic 
applications. 
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OVERALL SUMMARY 
The studies presented in Chapter 1 examined the respiratory pathways prior to and 
after a cervical SCI. First, utilizing the selective, activity dependent uptake of WGA (Harrison 
et al., 1984, 1986; Jankowska, 1985; Schwab et al., 1979), spinal cord and brain stem nuclei 
were identified with a fluorescent neuronal tracer, WGA-Alexa 488. WGA-Alexa 488 has an 
advantage over the traditionally used WGA-HRP since the Alexa 488 portion is readily 
identified with fluorescent microscopy. Eliminating the need for chemical reactions to 
visualize HRP has provided a method to visualize the neurons responsible for diaphragm 
activity while maintaining the integrity of the tissue for further biochemical or molecular 
analysis.  
Injection of WGA-Alexa 488 into the ipsilateral hemidiaphragm following a C2Hx 
resulted in bilateral labeling of the phrenic motoneurons in the cervical spinal cord as well 
as the premotor rVRG neurons in the medulla. However, following WGA-Alexa 488 
exposure to the isolated ipsilateral phrenic nerve following a C2Hx, labeling was only 
identified in the ipsilateral phrenic nuclei. This observation suggests that WGA-Alexa 488 
must be exposed to the phrenic axon terminal at the neuromuscular junction in order for 
transsynaptic transport to occur.  
 Once the labeling properties of WGA-Alexa 488 were identified and found to be 
reproducible in the acute C2Hx model, the tracer was then characterized in the chronically 
injured system. Following a C2Hx, the ipsilateral diaphragm is paralyzed with the exception 
of intermittent activity stimulated by the crossed phrenic pathway (CPP). Over time the 
diaphragm can regain phasic activity, this is referred to as spontaneous recovery (Nantwi 
et al., 1999). Since the CPP circuitry is already in place, it would seem that spontaneous 
recovery is a result of strengthening the CPP. To determine the nuclei associated with 
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spontaneous recovery, rats underwent a C2Hx followed by a 12-week recovery period. At 
12-weeks WGA-Alexa 488 was injected into the ipsilateral hemidiaphragm. Interestingly not 
only was WGA-Alexa 488 identified bilaterally in the phrenic nuclei and the rVRGs but was 
also identified in numerous spinal cord and brain stem nuclei. The change in labeling 
demonstrates injury induced plasticity following SCI. Many of the labeled nuclei have been 
linked to respiration as motor nuclei for accessory respiratory muscle, or nuclei that help 
regulate and coordinate respiration with body functions. Therefore, the presence of WGA-
Alexa 488 in the nuclei (forelimb motoneurons, RST, DSCT, and VSCT) unique to the 
chronically injured model is likely caused by hyperactivity of existing pathways. WGA-Alexa 
488 labeling in the medulla for the acutely C2Hx and chronically C2Hx were strikingly 
different. The acutely C2Hx rats displayed WGA-Alexa 488 labeling isolated to the rVRGs. 
However, the chronically C2Hx rats, in addition to the rVRGs, displayed labeling in the 
raphe, hypoglossal, spinal trigeminal, parvicellular reticular, gigantocellular reticular, and 
intermediate reticular nuclei. All of these have been previously demonstrated, using 
alternative tracers, to be associated with respiratory control in acutely hemisected or non-
injured rats. It is important to point out that WGA-Alexa 488 only labels these nuclei in the 
chronically injured system. This further emphasizes the selective activity-mediated uptake 
of WGA bound conjugates.  
 Similar to the chronically C2Hx rats, the sham C2Hx rats also displayed bilateral 
WGA-Alexa 488 labeled interneurons primarily in laminae VII and VIII of the cervical and 
thoracic cord and bilateral labeled intercostal motoneurons in the thoracic spinal cord. 
These results imply that the sham C2Hx surgery including laminectomy of C2, durotomy, 
and laparotomy had an impact on the spinal cord environment. Interestingly, the supraspinal 
nuclei appeared unaffected by the sham C2Hx and presented WGA-Alexa 488 labeling 
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indistinguishable from the acute C2Hx rats. Thus, we can conclude that hemisection of the 
spinal cord induces changes in the supraspinal circuitry. The use of WGA-Alexa 488 as a 
neuronal tracer to detect changes in physiologically active synapses post injury proves to 
be a valuable tool to identify areas of injury induced plasticity. 
In the last study of Chapter 1, WGA-Alexa Fluorochromes were administered to 
acutely C2Hx and non-injured rats by intradiaphragmatic and intrapleural injections. 
Intrapleural injections were investigated as an alternative method to the invasive procedure 
required to administer intradiaphragmatic injections. Following intrapleural injection, the PN, 
intercostal SC nuclei, rVRGs, and unexpectedly the nucleus ambiguus (NA) were all 
bilaterally labeled. A direct connection from the NA to the PN has yet to be defined, 
suggesting that WGA-Alexa fluorochromes are capable of undergoing transsynaptic 
transport across at least 2 synapses. This finding is of interest especially in respect to the 
application of WGA-Alexa in the chronically injured system. Understanding the order of 
activation may help determine the role each nuclei plays in spontaneous recovery. The 
availability of neuronal tracers capable of crossing one, multiple, select, or all synapses 
allows investigators to implement these techniques to ask questions related to neuronal 
synapses and changes following injury and treatment.  
In the final two chapters, following an acute or chronic SCI, a novel nanoconjugate 
was administered to stimulate activation of the phrenic nuclei and diaphragm. Following a 
C2Hx there is a loss of ipsilateral hemidiaphragm function. In the rodent injury model 
adenosine antagonists, such as theophylline, are able to stimulate the functionally latent 
CPP and restore hemidiaphragm function. However, in humans the therapeutic dose of 
theophylline results in hyperactivity of many non-target nuclei. To reduce the administered 
dose, theophylline was conjugated to the neuronal tracer WGA-HRP, using a gold 
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nanoparticle (AuNP) as a coupler. Following intradiaphragmatic injection of the tripartite 
nanoconjugate, WGA-HRP is expected to mediated endocytosis at the axon terminal of 
phrenic motoneurons. Once the nanoconjugate is endocytosed, the transient ester bond 
linking the drug to the AuNP is degraded, freeing the drug. By targeting the drug to only the 
neurons associated with diaphragm function, the dose needed to stimulate hemidiaphragm 
activity is greatly reduced.  
To investigate the effectiveness of the tripartite nanoconjugate in the acutely injured 
system, rats were subjected to a C2Hx followed by intradiaphragmatic injection of the 
theophylline bound nanoconjugate. Although the nanoconjugate was able to induce 
recovery at the level of the phrenic nerve and the diaphragm, the amount of recovery was 
rather small with a maximum average percent recovery of 5.12±0.8%.  
It is known that the nanoconjugate is able to undergo receptor mediated 
endocytosis, due to identification of the WGA portion of the nanoconjugate post injection in 
the phrenic nucleus and rVRGs. However, the amount of nanoconjugate uptake needs to 
increase. Several areas for improvement have been identified, including the injection of a 
diluted nanoconjugate solution to determine if aggregation of the AuNPs are creating an 
issue with uptake. These studies are planned and are not within the scope of this 
dissertation. Regardless of the complications with the theophylline version of the 
nanoconjugate, it is still important to point out that the nanoconjugate is capable of 
undergoing WGA mediated endocytosis followed by transsynaptic transport. There are 
numerous options as to what drug can be bound to the AuNPs. For example, replacing 
proTHP with DPCPX induces a superior recovery of LPN activity. 
Lastly, the final chapter examines the application of the tripartite nanoconjugate in 
the chronically C2Hx rat model. The WGA-Alexa 488 chronic study provided an 
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exceptionally detailed anatomical picture of the spinal and supraspinal nuclei that undergo 
injury induced plasticity and synaptic activity modification. Based on WGA mediated uptake, 
the nanoconjugate is expected to undergo transport to the nuclei identified with WGA-Alexa 
488 in the chronic C2Hx model. The chronically injured system has remained challenging 
to work with and responds differently to drugs than the acutely injured system (Nantwi et 
al., 2003a). The 0.06mg/kg dose showed a significant effect over the remaining two doses 
based on phrenic nerve recordings. However, rats with spontaneous recovery of the 
diaphragm also showed a significant advantage over those with no spontaneous recovery 
when comparing the average percent integrated waveforms. Endocytosis of WGA has been 
shown to be activity dependent. Thus suggesting rats exhibiting spontaneous recovery 
following chronic injury would have enhanced transport of the nanoconjugate, increasing 
drug exposure. Application of the tripartite nanoconjugate in the chronically injured system 
requires additional in-depth investigations to fine tune the drug dose, AuNP concentration, 
and alternative drugs. With these findings, utilizing WGA to selectively deliver drugs has 
potential clinical applications to increase respiratory output following SCI.   
These studies show that WGA is able to selectively transport WGA-bound 
conjugates, specifically Alexa fluorochromes and drug bound AuNPs, to nuclei that regulate 
diaphragm function in the non-injured and acutely and chronically C2Hx rat models. In 
addition to the respiratory motor pathway, WGA has been investigated in numerous 
neuronal pathways. The findings presented here, have the potential for applications in any 
system demonstrated to facilitate the selective uptake of WGA.   
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MATERIALS AND METHODS 
Animal Use 
 Adult male Sprague Dawley rats were used in these studies. All animal studies were 
approved by the Wayne State University School of Medicine Institutional Animal Care and 
Use Committee.  
Second Cervical Segment Spinal Cord Hemisection (C2Hx) 
 All rats were injected with atropine sulfate (0.04mg/kg, im) 10 minutes prior to 
anesthesia induction to reduce mucus secretions during the subsequent aseptic survival 
surgery. Anesthesia was a mixture of ketamine (70mg/kg, ip) and xylazine (7mg/kg, ip). 
After anesthesia induction, bupivacaine (2mg/kg, sc) a local anesthetic was injected into 
the dorsal neck. The dorsal aspect of the neck was shaved and prepared for aseptic 
surgery.  An incision was made on the dorsal neck to expose the second cervical vertebra 
(CV2). The paravertebral muscles were cut and retracted along the midline axis. All muscle 
attachments to CV2 were cut to expose the spinous processes, laminae, and the 
intervertebral space between CV1/CV2 and CV2/CV3. A bilateral laminectomy was 
completed at the level of CV2 to expose the spinal cord. A durotomy was performed with 
spring micro-scissors. After locating the C2 and C3 dorsal roots, the left half of the spinal 
cord was cut just to the left of midline and continued to the lateral aspect of the cord caudal 
to the C2 dorsal root. Care was taken to avoid cutting the large dorsal blood vessel that 
typically courses along the midline of the spinal cord. The location of the hemisection also 
avoids the anterior spinal artery on the ventral aspect of the spinal cord. The functional 
completeness of the injury was confirmed with EMG of the diaphragm (see EMG Analysis). 
The dorsal neck muscles were closed using 4-0 absorbable sutures (Vicryl, Ethicon) 
followed by wound clips (Reflex® 9mm) for the skin. Following the cleaning of the cervical 
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incision, the rats were injected with Buprenorphine (0.01mg/kg, sc) in 10ml saline for pain 
control and yobine (2mg/kg, ip) to reverse xylazine. The following 48 hours, post-operative 
rats were given additional injections of Buprenorphine (0.01mg/kg, sc) every 8-12 hours for 
pain management. The rats recovered on a heating blanket on their back to limit pressure 
on the diaphragm. When the rats were able to ambulate, they were returned to clean litter-
lined cages with food and water provided ad libitum on the floor of the cage to minimize 
neck movement during recovery. The rats were also given peanut butter and cereal as an 
enticement to eat. 
Sham Second Cervical Segment Spinal Cord Hemisection 
 Rats underwent an identical hemisection surgical procedure described above up to 
and including the durotomy, but the spinal cord was not cut.   
Electromyography Analysis 
 Immediately following the left C2Hx or sham C2Hx, paralysis of the ipsilateral 
hemidiaphragm was confirmed by EMG analysis. The abdominal surface of the diaphragm 
was exposed by a 6-8 cm horizontal incision made approximately 0.5 cm caudal and parallel 
to the costal margin. Bipolar platinum wire electrodes (Grass F-E2) were inserted 
intramuscularly within each side of the diaphragm to detect muscle activity. Signals were 
amplified (20,000X) and band pass-filtered (30Hz-3kHz) by Grass amplifiers (model P511 
AC, Astro-Med, Inc., West Warwick, RI) and raw EMG signals were recorded by a 
Cambridge Electronic Design (CED, Cambridge, England) data acquisition system 
integrated with CED Spike 2® software. Recordings were taken from three areas of the left 
hemidiaphragm: anterior (sternal), lateral (costal) and posterior (crural). Only rats that 
showed a complete absence of activity in all three areas were included in the study.  
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In all chronic rats a second EMG to test for spontaneous recovery was assessed 
immediately prior to the injection of WGA-Alexa fluor conjugates, nanoconjugate, or control 
solutions.  
Rats that received a nanoconjugate or control solution were assessed with EMG 
analysis an additional 1-3 times depending on the length of the experiment. All subsequent 
EMG recordings were performed under ketamine/xylazine anesthesia while spontaneously 
breathing.  
Following the EMG, the abdominal cavity was closed using 4-0 absorbable sutures 
(Vicryl, Ethicon) followed by wound clips (Reflex® 9mm) for the skin. Postoperative care for 
the first 48 hours was identical to the care described above after C2Hx.  
Acute Studies 
 Acute is defined as up to 14 days following SCI. Dependent on the study, rats 
survived a minimum of 48 hours or up to 14 days. 
Chronic Studies 
 Hemisected rats recovered for a period of at least 7 weeks with no intervention with 
respect to respiratory function. Several rats required medical attention for issues such as 
wounds associated with the incision site or eye, or autophagy of the right hind paw. When 
needed and as prescribed by the veterinarian, topical application of triple antibiotic ointment, 
silver sulfadiazine, or Columbia powder was used to manage wounds. In addition, 
Buprenorphine (0.01mg/kg, sc) or Carprofen (5mg/kg, sc) was administered for pain 
management. To prevent autophagy of the right rear paw a topical mixture of New Skin and 
metronidazole (500mg/mL MP Biomedicals 0215571005) was applied to the right rear paw 
weekly (Zhang et al., 2001). Prior to implementing the topical paw treatment, several rats 
had to be euthanized prior to completion of the study due to the severity of rear paw wounds.  
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Intradiaphragmatic injections of WGA-Alexa fluor conjugates 
Intradiaphragmatic injections of WGA-Alexa fluor conjugates were administered; i) 
following a laparotomy to expose the abdominal surface of the diaphragm (non-injured), ii) 
following EMG confirmation of hemidiaphragm paralysis (acutely injured), iii) following an 
EMG at 12 weeks post C2Hx (chronically inured). All injections were administered using a 
28 gauge Hamilton syringe (catalog # 7637-01, and # 7803-02). Rats were injected with 
either 2% WGA- Alexa 594 (Life Technologies Cat. # W11262) saline solution or 2% WGA-
Alexa 488 (Life Technologies Cat. # W11261) in saline solution into the left hemidiaphragm. 
A total of 50µl was administered to each rat in 10µl increments. The amount of tracer 
injected was based on a previous study (Moreno et al., 1992) which determined that five 
10µl injections distributed from the anterior to posterior region of the hemidiaphragm were 
sufficient to label the phrenic nucleus that spans the C3-C6 segments of the cervical spinal 
cord. All rats were sutured as described in the EMG analysis section and survived for 48 
hours.  
Intradiaphragmatic injections of nanoconjugate or control solutions 
 A detailed description of the synthesis of the proTHP nanoconjugates can be found 
in the following manuscript: “Transporter protein and drug-conjugated gold nanoparticles 
capable of bypassing the blood-brain barrier” Zhang et al., 2016. Intradiaphragmatic 
injections of the nanoconjugate or a control solution; i) WGA-HRP-AuNP, ii) AuNP-ProTHP, 
iii) ProTHP were administered following EMG confirmation of hemidiaphragm paralysis 
(acutely injured), or following an EMG at 8-12 weeks post C2Hx (chronically inured). All 
injections were administered using a 28 gauge Hamilton syringe (catalog # 7637-01, and # 
7803-02). The total volume of the solution injected was weight based and dependent on the 
concentration of the drug in the solution. Volume of the control solutions were calculated 
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identical to the drug based solutions to eliminate variance based on volume. All solutions 
were injected in 10µl increments or less and were distributed from the anterior to posterior 
region of the hemidiaphragm (Fig. 50). Following injection, the needle was slowly retracted 
to prevent any leaks at the injection site. Rats survived for 3-14 days depending on the 
timeline for each experimental group.  
 
Figure 50: Intraoperative view of nanoconjugate injection sites. Exposure of the 
abdominal surface of the left hemidiaphragm following injections of the WGA-HRP-AuNP-
proTHP nanoconjugate into the left hemidiaphragm. Injection sites are clearly visualized 
due to the black coloration of the nanoconjugate solution. 
 
Intact Phrenic Nerve Soak 
Rats received a soak treatment of 2% WGA-Alexa 488 applied to the isolated left 
phrenic nerve for 1 hour immediately after a C2Hx or sham surgery. The cervical phrenic 
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nerve was approached ventrally and isolated from the underlying brachial plexus with fine 
forceps and cotton swabs. The sheath of the nerve was carefully removed with fine forceps. 
Photographic images of the nerve were captured at 40X on an Olympus C-5050 digital 
camera attached to a Zeiss surgical microscope (Fig. 8). A cup created by cutting off the 
bottom of a 1.5ml microcentrifuge tube was placed under the phrenic nerve. Small pieces 
of bench top paper were placed around the cup to absorb fluid produced by the surrounding 
tissue during the 1-hour treatment. 1.5µl of 2% WGA-Alexa 488 were placed in the cup with 
a micropipette. The surgical field was covered with a piece of gauze moistened in sterile 
saline to prevent tissues from drying out during treatment. After 1 hour, the remaining WGA-
Alexa 488, the cup and the bench paper was removed and the area was gently swabbed to 
remove excess fluid. The muscles were sutured with 4-0 absorbable suture (Vicryl, Ethicon) 
followed by 4-0 non-absorbable nylon suture (Ethilon, Ethicon) to close the skin. The rats 
survived for 48 hours. 
Intrapleural Injection 
Rats received a transcutaneous intrapleural injection administered through the fifth 
intercostal space into the thoracic cavity on the right side as described by Mantilla et al., 
2009. All rats received 50µl of 2% WGA-Alexa 488 saline solution administered with a 25 
gauge by 5/8” needle syringe (Buttry and Goshgarian, 2015). It is important to note that 
advancing the needle too far will result in an injection into the lung parenchyma.  
Vagus Nerve Injection 
 The right vagus nerve was exposed by an incision of the ventral neck. The vagus 
nerve was identified based on the anatomical relationship with the jugular vein and the 
carotid artery. A Hamilton syringe was used to inject 1µl of a neuronal tracer into the right 
vagus nerve; rats were injected with 5% True blue chloride (TB, Santa Cruz Biotechnology, 
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Inc. Cat. # sc-216026) aqueous solution, or a 2% WGA-Alexa 594 (Life Technologies Cat. 
# W11262) saline solution. The surrounding area was examined for any signs of leakage. 
The neck muscles were sutured with 4-0 absorbable sutures (Vicryl) followed by closure of 
the skin with 4-0 non-absorbable nylon sutures (Ethilon). 
Tissue preparation of WGA-Alexa fluor conjugate injected rats 
Forty-eight hours after injections, rats were anesthetized with urethane (1.6 g/kg, ip) 
and transcardially perfused with 150 mL saline followed by 300 mL of 4% paraformaldehyde 
in 0.1M phosphate-buffered saline (pH 7.4). The spinal cord (cervical through thoracic) and 
medulla were removed and an insect pin was inserted along the longitudinal axis of both on 
the left to differentiate the left from the right side. The medullary and spinal tissue was then 
post-fixed in the perfusate overnight and cryoprotected 2-3 days in 30% sucrose in 0.1M 
PBS until the tissue sank. Transverse, horizontal, or sagittal sections through the medulla 
and spinal cord were cut in 40µm thick sections with a cryostat and collected in 0.1M PBS. 
Every section from the medulla was saved, whereas every 3rd spinal cord section was 
saved. Sections were then washed in 0.1M PBS and mounted on Poly-L-lysine treated 
slides. The sections were cover slipped with Fluoromount (Sigma cat. # F4680) and 
examined with a Zeiss Axiophot fluorescent microscope using the 488 filter (green), 594 
filter (red), and the Dapi filter (blue). Images were captured using the Axio Vision Rel. 4.8 
Program.  
Autofluorescence is not problematic when examining WGA-Alexa tracers due to the 
distinct granulation within the WGA-Alexa labeled cells (Goshgarian and Buttry, 2014). 
However, True blue labeled cells have a hazy appearance throughout the cell body. To 
reduce the chance of counting false positive True blue labeled cells, images were captured 
with exposure times that resulted in a dark background. For cell counts, cells were 
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considered labeled with True blue if the cell body was clearly identifiable and brightly 
illuminated compared to the dark background. Cells were considered labeled with WGA-
Alexa fluor conjugate if the cell body was clearly identifiable and displayed granulation 
characteristic of the tracer. Neurons labeled with WGA-Alexa fluor conjugates are 
exceptionally bright and can be easily seen at low magnification. Positively labeled neurons 
always have distinct granules that can be seen clearly at higher magnification. Non-labeled 
neurons do not display granulation with in the cell boundaries. Cells on every other section 
from the medulla were counted since every section was saved after sectioning the tissue; 
this was to avoid counting the same cell body twice. Since every 3rd section from the spinal 
cord was saved, cells were counted on every spinal cord section saved. A cell was 
considered labeled if the cell body with a nucleus was identifiable.  
Bilateral Phrenic Nerve Recordings/Electrophysiology 
The groups designated for bilateral phrenic nerve recordings included rats with 
varying doses of nanoconjugate, and rats that received injection of one of the control 
solutions; i) WGA-HRP-Au, ii) AuNP-ProTHP, iii) WGA-HRP-AuNP-ProTHP intravenous, iv) 
proTHP intradiaphragmatic. Bilateral phrenic nerve recordings were sampled at day 3, 7, 
and 14 for acute studies and at 13 weeks for chronic studies. The rats were injected with 
atropine sulfate (0.06mg/kg, im) 10 minutes prior to anesthesia induction to reduce mucus 
secretions during the procedure. The initial dose of anesthesia was a mixture of ketamine 
(70mg/kg, ip) and xylazine (7mg/kg, ip). A supplement of ketamine (17mg/kg, ip) and 
xylazine (2mg/kg, ip) was provided as needed. The femoral vein was cannulated for drug 
and fluid delivery. The femoral artery was cannulated to monitor blood pressure (World 
Precision Instruments, #SYS-BP1). The blood pressure was maintained in the range of 90-
105 mmHg by injection of Lactated Ringer’s (Baxter) as needed. The right and left phrenic 
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nerve were exposed by an incision to the ventral neck. The phrenic nerves were dissected 
from the underlying brachial plexus and carefully de-sheathed with fine forceps and cotton 
swabs. The right and left vagus nerves were dissected and the trachea was dissected to 
prepare for a tracheotomy. The rats were ventilated with a mixture of room air and oxygen. 
A bilateral vagotomy and phrenicotomy was performed. The phrenic nerves were cut to 
eliminate afferent activity. The proximal portions of the cut right and left phrenic nerves were 
then placed on bipolar platinum electrodes (Grass F-E2). Signals were amplified (20,000X) 
and band pass-filtered (30Hz-3kHz) by Grass amplifiers (model P511 AC, Astro-Med, Inc., 
West Warwick, RI), raw and integrated signals were recorded by a Cambridge Electronic 
Design (CED, Cambridge, England) data acquisition system integrated with CED Spike 2® 
software. Once the phrenic nerves were stable in the setup, standardized conditions were 
achieved. The rats were paralyzed with pancuronium bromide (0.5mg/kg iv); and the apneic 
threshold was determined. To determine the apneic threshold (the lowest PaCO2 at which 
a subject will remain apneic (temporary stop breathing)), the ventilator frequency was slowly 
turned up until the phrenic nerve signal disappeared (ventilator is doing all the work and the 
system is flooded with O2 therefore the brain stem does not need to send a signal to 
contract diaphragm/breath and rid the body of CO2). The ventilator was then turned down 
slowly until the recruitment threshold was found and the rat began to breathe again (bursting 
signal re-appears on neurogram). The CO2 level was maintained at the recruitment 
threshold, 3 to 5 mmHg above the apneic threshold (Fig. 51). Once the rat was stable under 
standardized conditions the bilateral phrenic nerve recordings and blood pressure were 
recorded on the Spike 2® software. Blood pressure was monitored and intravenous fluids 
(Lactated Ringers) were provided as needed.  
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Figure 51: Example neurograms identifying the apneic and recruitment thresholds. 
The top trace displays a neurogram of the right phrenic nerve demonstrating the bursting 
pattern used to identify the apneic threshold. When the level of oxygen is increased the 
descending signal from the rVRG is inhibited resulting in an absence of phrenic nerve 
activity. An absence of signal for a minimum of 7 seconds is used to identify apnea, above 
is a 13 second pause. Once apnea is identified, the end tidal CO2 level is set 3-5mmHG 
higher by slowly decreasing the oxygen to the ventilator. The bottom trace displays a 
neurogram after the apneic threshold had been identified and the end tidal CO2 levels were 
adjusted. The stimuli to breath is stable and consistent as demonstrated by the consistent 
bursting pattern displayed on the neurogram. 
 
The rats were tested for presence or absence of recovered phrenic nerve activity 
followed by quantification of the neurograms that demonstrate bilateral phrenic nerve 
activity (see statistical analysis below).  
Tissue preparation to visualize WGA 
Three days after intradiaphragmatic injection of WGA-HRP-AuNP-proTHP, rats 
were anesthetized with a mixture of ketamine (70mg/kg, ip) and xylazine (7mg/kg, ip). The 
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rats were transcardially perfused with 150 mL of heparinized saline followed by 350 mL of 
4% Formaldehyde in 0.1M phosphate-buffered saline (pH 7.4). The spinal cord (C3-C6) and 
medulla were removed and an insect pin was inserted along the longitudinal axis of both on 
the right to differentiate the left from the right side. The medullary and spinal tissues were 
post-fixed in the perfusate overnight and cryoprotected 2-3 days in 30% sucrose in 0.1M 
PBS until the medulla sinks. Transverse sections (50microns) through the medulla and 
spinal cord were cut with a cryostat and collected in 0.1M PBS.  
Tissue sections were washed in immunobuffer for 10 minutes (x3) followed by 
incubation in 10% Normal Horse Serum (NHS) blocking solution for 30 minutes. Sections 
were incubated in a primary antibody, anti-WGA made in goat (Vector labs, batch 2024) 
with a 1:200 concentrations in 10% NHS. Sections remained in the primary antibody for 72 
hours. Sections were then washed in Tris-PBS for 10 minutes (x3). Sections where then 
incubated in a secondary antibody, Biotin-Donkey anti-goat (Jackson ImmunoResearch, 
batch 113055) with a 1:400 concentrations in 1%NHS. Sections remained in the secondary 
antibody for 24 hours. The sections were washed in Tris-PBS for 10 minutes (x3). Sections 
were then incubated in Cy 3 Streptavidin (Jackson ImmunoResearch) diluted in 
immunobuffer with a 1:1000 concentration for 4 hours. After the addition of Cy 3 Streptavidin 
the sections were covered in foil to limit exposure to lights. Sections were washed in Tris-
PBS for 10 minutes (x3) and mounted on slides. Buffered glycerol (pH 8.6) was placed on 
to the sections and covered slipped (Strack and Loewy, 1990). Tissue sections were 
examined on a Zeiss Axioimager.M2 fluorescent microscope using the red filter. Images 
were captured using the Zen 2 pro Blue edition program.  
Statistical analysis of EMG and neurogram recordings 
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 All statistical test of EMG data was performed in SigmaPlot 13.0. Qualitative analysis 
of EMG data was performed as described by Minic et al., 2016. As stated by Minic et al., 
2016 only the incidence of recovery was quantitated not the amount of recovery. Treatment 
groups were divided into a Yes or No category based on recovery (return of function to the 
left hemidiaphragm) or the absence of activity respectfully. Recovery was classified as a 
return of activity in any two sections of the left hemidiaphragm (anterior, lateral, posterior). 
For comparison between two groups, the Fisher exact test was performed to determine if 
the ratio of Yes/No for each group was statistically different.  When more than two groups 
were being compared, the Chi-square test with alpha = 0.010 was performed to determine 
if there was significance within the group as a whole. In addition to the Chi-square, each 
group was compared pairwise with the Fisher exact test to identify significance between 
each pair of groups. All graphs for EMG data were made in Excel.  
Data was obtained from the bilateral phrenic nerve recording procedure once the 
apneic threshold was established and the rat was stabilized near the recruitment threshold. 
Once stabilized 10 consecutive breaths were sampled (Fig. 52). The sampled data from 
Spike was exported to Excel. The baselines (noise) for the 10 breaths of the right and left 
neurograms, determined in Spike, were subtracted from the right a left set of data points 
respectfully in Excel. The area under the curves (AUC) from the right and left rectified and 
integrated waveforms (INT) were calculated. The percent recovery of the left INT compared 
to the right INT (right=100%) was calculated for each breath, then the average % INT was 
calculated. Then the maximum amplitude was identified for each of the 10 breaths. The 
percent maximum amplitude (MAX) of the left compared to the right (right=100%) was 
calculated for each breath, then the average % MAX was calculated. The average % INT 
and the average % MAX for each group was averaged. The average percent recovery for 
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INT and MAX from each group was then compared and subjected to statistical examination 
using SigmaPlot 13.0. All groups underwent One-way ANOVA (alpha=0.050) followed by 
Holm-Sidak pairwise comparison to determine the effect of the injected solution on the 
percent recovery and percent max recovery. All graphs for neurogram data were made in 
SigmaPlot 13.0.  
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Figure 52: Phrenic nerve tracing. The neurogram displayed here was recorded on day 7 
post injection. L Int, integrated left waveform; LPN, left phrenic nerve signal in volts; R Int, 
integrated right waveform; RPN, right phrenic nerve signal in volts. The top trace is a sample 
of the neurogram that spans over 130 seconds. The bottom trace is a sample of 10 breaths 
from the boxed area in the top trace. To calculate LPN recovery, background was 
subtracted from the integrated waveforms. Then the area under the curve was calculated 
for the R and LPN. Left was expressed as a percentage of right. In addition, the maximum 
amplitude for each burst was calculated from the R and L integrated waveforms and the left 
was expressed as a percentage of right. 
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APPENDIX 
Nanoconjugate Patent Information 
The work presented herein has been submitted for patenting: “Transporter Protein-
Coupled Nanodevices for Targeted Drug Delivery”, First Named Inventor/Applicant Name: 
Harry Goshgarian (co-inventors: Guangzhao Mao, Yanhua Zhang). Original Assignee: 
Wayne State University. Application number: 14/534,994, Application type: Utility/Design 
using an application data sheet (37 CFR 1.76), Date Filed: November 6, 2014. Publication 
number: US20150125926 A1. 
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Second cervical segment spinal cord hemisection (C2Hx) results in ipsilateral 
hemidiaphragm paralysis. However, the intact latent crossed phrenic pathway can restore 
function spontaneously over time or immediately following drug administration.  
WGA bound fluorochromes were administered to identify nuclei associated with 
diaphragm function in both the acute and chronic C2Hx models. WGA is unique in that it 
undergoes receptor mediated endocytosis and is transsynaptically transported across 
select physiologically active synapses. Comparison of labeling in the acutely injured to the 
chronically injured rat provided an anatomical map of spinal and supraspinal injury induced 
synaptic plasticity. The plasticity occurs over time in the chronic C2Hx model in an effort to 
adapt to the loss of hemidiaphragm function.  
Utilizing the selectivity of WGA, a nanoconjugate was developed to target drug 
delivery to nuclei involved in diaphragm function post C2Hx in an effort to restore lost 
function. Theophylline was selected due to its established history as a respiratory stimulant. 
Theophylline was attached to gold nanoparticles by a transient bond designed to degrade 
intracellularly. The gold nanoparticles were then permanently attached to WGA-HRP. 
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Following intradiaphragmatic injection, the WGA portion was identified in the ipsilateral 
phrenic nuclei and bilaterally in the rVRGs. The location of WGA should reflect the location 
of the AuNP since the peptide bond between them is permanent.  
The effectiveness of the nanoconjugate was verified with EMG analysis of the 
diaphragm and recordings from the phrenic nerves. All doses administered in the acute 
C2Hx model resulted in resorted hemidiaphragm and phrenic nerve activity. A dose of 
0.14mg/kg had a significantly higher percent recovery on day 3, whereas 0.03mg/kg was 
significantly higher on day 14. The change in most effective dose over time is likely due to 
the availability or concentration of the drug and location of drug release. Administration of 
the nanoconjugate was also characterized in the chronically C2Hx model. The dose 
0.06mg/kg resulted in significant recovery when injected 12 weeks post-C2Hx. This data 
suggests that WGA bound nanoconjugates are able to undergo endocytosis. In addition, 
the theophylline bound nanoconjugate is capable of restoring hemidiaphragm and phrenic 
nerve activity.  
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